<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="report"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD with OASIS Tables v1.0 20120330//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing-oasis-article1.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName jpoasis-nisons2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Cell Cycle</journal-id><journal-id journal-id-type="iso-abbrev">Cell Cycle</journal-id><journal-id journal-id-type="publisher-id">KCCY</journal-id><journal-id journal-id-type="publisher-id">kccy20</journal-id><journal-title-group><journal-title>Cell Cycle</journal-title></journal-title-group><issn pub-type="ppub">1538-4101</issn><issn pub-type="epub">1551-4005</issn><publisher><publisher-name>Taylor &amp; Francis</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5053590</article-id><article-id pub-id-type="pmid">27295129</article-id><article-id pub-id-type="publisher-id">1198862</article-id><article-id pub-id-type="doi">10.1080/15384101.2016.1198862</article-id><article-categories><subj-group subj-group-type="heading"><subject>Report</subject></subj-group></article-categories><title-group><article-title>Investigating core genetic-and-epigenetic cell cycle networks for stemness and carcinogenic mechanisms, and cancer drug design using big database mining and genome-wide next-generation sequencing data</article-title><alt-title alt-title-type="running-authors">C.-W. LI AND B.-S. CHEN</alt-title><alt-title alt-title-type="running-title">CELL CYCLE</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Li</surname><given-names>Cheng-Wei</given-names></name><xref ref-type="aff" rid="af0001"/></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Bor-Sen</given-names></name><xref ref-type="aff" rid="af0001"/></contrib><aff id="af0001"><institution>Department of Electrical Engineering, National Tsing Hua University</institution>, Hsinchu, <country>Taiwan</country></aff></contrib-group><author-notes><corresp id="an0001"><bold>CONTACT</bold> Bor-Sen Chen <email xlink:href="bschen@ee.nthu.edu.tw">bschen@ee.nthu.edu.tw</email>; Cheng-Wei Li <email xlink:href="cwlitw@gmail.com">cwlitw@gmail.com</email></corresp><fn><p>Color versions of one or more of the figures in this article can be found online at <ext-link ext-link-type="uri" xlink:href="http://www.tandfonline.com/kccy">www.tandfonline.com/kccy</ext-link>.</p></fn><fn><p>Supplemental data for this article can be accessed on the <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1080/15384101.2016.1198862">publisher's website</ext-link>.</p></fn></author-notes><pub-date pub-type="collection"><year>2016</year></pub-date><pub-date pub-type="epub"><day>13</day><month>6</month><year>2016</year></pub-date><pub-date pub-type="pmc-release"><day>13</day><month>6</month><year>2016</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>15</volume><issue>19</issue><fpage seq="13">2593</fpage><lpage>2607</lpage><history><date date-type="received"><day>6</day><month>4</month><year>2016</year></date><date date-type="rev-recd"><day>26</day><month>5</month><year>2016</year></date><date date-type="accepted"><day>2</day><month>6</month><year>2016</year></date></history><permissions><!--<copyright-statement content-type="description"> &#x000a9; Cheng-Wei Li and Bor-Sen Chen. <copyright-statement>--><copyright-statement>&#169; 2016 The Author(s). Published with license by Taylor &amp; Francis.</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>The Author(s)</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The moral rights of the named author(s) have been asserted.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="kccy-15-19-1198862.pdf"/><abstract><title>ABSTRACT</title><p>Recent studies have demonstrated that cell cycle plays a central role in development and carcinogenesis. Thus, the use of big databases and genome-wide high-throughput data to unravel the genetic and epigenetic mechanisms underlying cell cycle progression in stem cells and cancer cells is a matter of considerable interest.</p><p>Real genetic-and-epigenetic cell cycle networks (GECNs) of embryonic stem cells (ESCs) and HeLa cancer cells were constructed by applying system modeling, system identification, and big database mining to genome-wide next-generation sequencing data. Real GECNs were then reduced to core GECNs of HeLa cells and ESCs by applying principal genome-wide network projection. In this study, we investigated potential carcinogenic and stemness mechanisms for systems cancer drug design by identifying common core and specific GECNs between HeLa cells and ESCs. Integrating drug database information with the specific GECNs of HeLa cells could lead to identification of multiple drugs for cervical cancer treatment with minimal side-effects on the genes in the common core. We found that dysregulation of miR-29C, miR-34A, miR-98, and miR-215; and methylation of <italic>ANKRD1, ARID5B, CDCA2, PIF1, STAMBPL1, TROAP, ZNF165</italic>, and <italic>HIST1H2AJ</italic> in HeLa cells could result in cell proliferation and anti-apoptosis through NF&#954;B, TGF-&#946;, and PI3K pathways. We also identified 3 drugs, methotrexate, quercetin, and mimosine, which repressed the activated cell cycle genes, <italic>ARID5B, STK17B</italic>, and <italic>CCL2</italic>, in HeLa cells with minimal side-effects.</p></abstract><kwd-group kwd-group-type="author"><title>KEYWORDS</title><kwd>big database mining</kwd><kwd>cell cycle projection method</kwd><kwd>cell cycle</kwd><kwd>carcinogenic mechanism</kwd><kwd>genetic-and-epigenetic cell cycle network</kwd><kwd>NGS data</kwd><kwd>stemness mechanism</kwd><kwd>systems pharmacology</kwd></kwd-group><counts><fig-count count="6"/><table-count count="2"/><ref-count count="90"/><page-count count="15"/></counts></article-meta></front><body><sec sec-type="intro" id="s0001"><title>Introduction</title><p>In general, the properties of stem cells, called &#8220;stemness,&#8221; include self-renewal and differentiation;<xref rid="cit0001" ref-type="bibr"><sup>1,2</sup></xref> whereas those of cancer non-stem cells, referred to as &#8220;cancerness,&#8221; comprise high mutation rates and cell cycle dysregulation that promotes cell proliferation. In 2011, Okita and Yamanaka<xref rid="cit0003" ref-type="bibr"><sup>3</sup></xref> proposed that the cell cycle played an important role in generating induced pluripotent stem cells. Stem cells regulate their cell cycle to undergo periods of rapid division or quiescence, maintain self-renewal, and avoid senescence.<xref rid="cit0004" ref-type="bibr"><sup>4</sup></xref> The cell cycle appears to influence stemness, cancerness, or both. Furthermore, recent evidence suggests that microRNAs (miRNAs) may control cell proliferation by influencing the level of a manifold of cell cycle regulators. Additionally, miRNAs are critical for human carcinogenesis and have been used as drug targets to control critical genes in cancer.<xref rid="cit0005" ref-type="bibr"><sup>5</sup></xref> It is now apparent that miRNAs play an important role in human carcinogenesis and aging.<xref rid="cit0006" ref-type="bibr"><sup>6-8</sup></xref> However, it is difficult to analyze genetic and epigenetic regulation simultaneously by applying traditional experimental analysis. Therefore, the switch between stemness and cancerness strategies in genetic and epigenetic regulation during cell cycle progression remains an unresolved issue.</p><p>Empirical evidence shows that telomeres, the segments of DNA at the ends of chromosomes, shorten slightly after each new cell division until they achieve a critical length, which triggers apoptosis; this phenomenon is called the Hayflick limit. Embryonic stem cells (ESCs) and cervical carcinoma HeLa cells present a highly active telomerase during cell division, which allows them to bypass the Hayflick limit and become immortal.<xref rid="cit0009" ref-type="bibr"><sup>9,10</sup></xref> In normal cells, anti-oncogenes or tumor suppressor genes regulate cell proliferation and cell cycle progression. It has been observed that cell cycle progression becomes aberrant or deregulated in nearly all transformed and neoplastic cells.<xref rid="cit0011" ref-type="bibr"><sup>11</sup></xref> Furthermore, recent studies have shown that miRNAs promote cell cycle progression in ESCs, thereby enabling their rapid proliferation.<xref rid="cit0012" ref-type="bibr"><sup>12</sup></xref> Testis-specific Y-encoded protein enhances cell proliferation and tumorigenesis by promoting cell cycle progression in HeLa cells.<xref rid="cit0013" ref-type="bibr"><sup>13</sup></xref> In addition, it has been suggested that cell cycle plays a major role in driving cervical cancer (i.e., HeLa cells).<xref rid="cit0014" ref-type="bibr"><sup>14</sup></xref> Both ESCs and HeLa cells are capable of promoting cell cycle progression through genetic and epigenetic regulation. This opens the possibility that a similar association could exist between ESCs and HeLa cells during cell cycle progression, which could be a crucial event to control cell properties, i.e., stemness or cancerness.</p><p>To date, the mechanisms underlying a number of complicated systems, such as ecosystems, biological, economic, and social systems, remain poorly understood owing to a fragmented distribution, and inconsistency in data reporting and literature. Big data has been defined as a set of techniques and technologies aimed at retrieving hidden information from large datasets that are diverse, complex, and of massive scale.<xref rid="cit0015" ref-type="bibr"><sup>15</sup></xref> An important issue that still needs to be addressed is the mining and integration of information from big data and expanding databases (big database) to construct an explanatory pattern or model (big mechanism) with which to uncover the overall mechanisms of these complicated systems.<xref rid="cit0007" ref-type="bibr"><sup>7,8,16-18</sup></xref> Next-generation sequencing (NGS) and microarray analysis, which can be regarded as big data techniques to a certain extent, still contain considerable amounts of information and hidden mechanisms that have never been extracted. Owing to the accuracy of NGS and the low cost of microarrays, they are commonly used for gene expression measurements. However, their simultaneous use in cellular network analysis has been rarely advocated. Moreover, the predictive value of cellular transcription regulation networks can be used to effectively find useful information and the corresponding mechanisms from gene expression data.<xref rid="cit0017" ref-type="bibr"><sup>17,19-21</sup></xref> Recent evidence indicates that the pathology of most cancers is a consequence of small abnormalities in many genes, whose added effect is to perturb healthy genetic-and-epigenetic networks.<xref rid="cit0022" ref-type="bibr"><sup>22</sup></xref> Accordingly, and in terms of treatment, cancer should be considered a systemic disease. Network analysis can provide scientists with a systematic approach to understand such complex and systemic diseases, which could not otherwise be understood in terms of a single target or pathway model.<xref rid="cit0023" ref-type="bibr"><sup>23</sup></xref></p><p>At present, correlation between gene expression coefficients remains the most widely used method to identify gene networks.<xref rid="cit0024" ref-type="bibr"><sup>24-26</sup></xref> However, correlation networks have undirected edges and no causality between genes. In this study, we constructed a dynamic system model that could characterize causal molecular mechanisms, such as the genetic regulation exerted by transcription factors (TF) and miRNAs on target genes. With this model, we applied a system identification method to identify real genetic-and-epigenetic cell cycle networks (GECNs) of ESCs and HeLa cells. This approach allowed us to further investigate carcinogenesis in cervical cancer and the stemness mechanism in stem cells using genome-wide microarray and NGS data. Furthermore, a systems cancer drug design method was also applied to the carcinogenic mechanism to select multiple drugs with minimal side-effects.</p><p>In order to investigate carcinogenesis and stemness mechanisms from a cell cycle perspective, the corresponding genes should first be identified. Hierarchical clustering of gene expression is the most popular method for identifying genes expressed during each cell cycle phase.<xref rid="cit0027" ref-type="bibr"><sup>27,28</sup></xref> Since these genes could be expressed in multiple cell cycle phases, in this study, we apply the cell cycle projection method to the genome-wide expression data to quantify the phase-specific ability of each gene at each cell cycle phase. By applying the cell cycle projection method to 4-phase high-throughput data, we obtained the cell cycle genes of the GECNs in ESCs and HeLa cells and used them toward big mechanism analysis of carcinogenic and stemness mechanisms.</p><p>Because the further analysis of the genome-wide network is complex to get more insight into carcinogenic and stemness mechanisms, we should extract the core networks from the real GECNs in ESCs and HeLa cells, respectively. Up to now, the core network was still identified by the connecting numbers of its nodes.<xref rid="cit0029" ref-type="bibr"><sup>29-31</sup></xref> As we could identify the connection weights of the real GECN using genome-wide expression data, we applied the principle genome-wide network projection (PGNP) to extract the core network from the viewpoint of significant genome-wide network structure. To investigate carcinogenesis and stemness mechanisms, the cancer-specific GECN, common core GECN, and stem-specific GECN were obtained through complexity reduction by applying PGNP to real GECNs of ESCs and HeLa cells. We could then identify cervical carcinogenic mechanisms by applying big mechanism analysis to help design potential multiple drugs for cervical cancer treatment. The flowchart to identify real GECNs of ESCs and HeLa cells and their core GECNs is shown in <xref ref-type="fig" rid="f0001">Fig.&#160;1</xref>.
<fig id="f0001" orientation="portrait" position="float"><label>Figure 1.</label><caption><p>Flowchart depicting the strategy to identify core GECN in HeLa and ES cells. In this study, we mined omics information from big databases, such as transcription and miRNA regulation interactions, to construct real GECNs using genome-wide high-throughput data, a dynamic model, and AIC. For drug screening, information was integrated from cervical carcinogenic mechanisms in cancer-specific GECN and drug databases for cervical cancer treatment.</p></caption><graphic specific-use="web-only" xlink:href="kccy-15-19-1198862-g001"/></fig>
</p><p>Systems pharmacology employs network analysis at multiple biological levels to understand both the therapeutic benefits and side-effects of drugs, and to design potential multiple drugs for cancer treatment.<xref rid="cit0023" ref-type="bibr"><sup>23,32</sup></xref> Based on the concept of systems pharmacology, we further designed multiple drugs for the decomposition of cancer-specific GECNs by integrating cervical carcinogenic mechanisms and drug databases.</p><p>In summary, we investigated the carcinogenic mechanisms of cervical cancer cells and the stemness of ES cells by applying big mechanism analysis to cell cycle progression. Based on these carcinogenic mechanisms, we designed multiple drugs for the treatment of cervical cancer. The proposed systematic design method may lead to drugs with high target specificity and minimal side-effects.</p></sec><sec sec-type="methods" id="s0002"><title>Material and methods</title><sec id="s0002-0001"><title>Data retrieval and pre-processing of NGS data in ESCs</title><p>Singh <italic>et&#160;al.</italic><xref rid="cit0033" ref-type="bibr"><sup>33</sup></xref> performed RNA-seq with NGS of ESCs in early G1 (DN), late G1 (KO2), S (AzLo), and G2/M (AzHi) phases. NGS data were obtained from the Gene Expression Omnibus (GEO) database (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/">https://www.ncbi.nlm.nih.gov/geo/</ext-link>), accession number GSE53481, in Sequence Read Archive (SRA) format. Reads were aligned to the human reference genome hg19 assembly. Alignment of RNA-seq reads against known genomic annotations downloaded from the University of California Santa Cruz web site (<ext-link ext-link-type="uri" xlink:href="http://www.genome.ucsc.edu">http://www.genome.ucsc.edu</ext-link>) was performed using Bowtie version 0.12.7 <xref rid="cit0034" ref-type="bibr"><sup>34</sup></xref> and TopHat version 1.5.0 software.<xref rid="cit0035" ref-type="bibr"><sup>35</sup></xref> We mapped these to gene and miRNA expression data employing Cufflinks 0.0.7 gene annotation <xref rid="cit0036" ref-type="bibr"><sup>36</sup></xref> on the Galaxy platform. <xref rid="cit0037" ref-type="bibr"><sup>37-39</sup></xref> We used cubic spline interpolation to obtain the expression of genes and miRNAs during G1, S, G2, and M phases.</p></sec><sec id="s0002-0002"><title>Data retrieval and pre-processing of microarray data from HeLa cells</title><p>Sadasivam <italic>et&#160;al.</italic><xref rid="cit0040" ref-type="bibr"><sup>40</sup></xref> reported the microarray gene and miRNA expression profiles of cells released from phase synchronization at 0 (G1), 2 (S), 4 (S), 6 (G2), 8 (M), and 12&#160;h (G1). In this study, 3 replicates were obtained from 3 independent experiments. The microarray data were obtained from the GEO database with accession number GSE26922. Gene and miRNA expression of the 4 cell cycle phases from 3 replications were obtained also by cubic spline interpolation. The mean expression of the replicates was then used to identify cell cycle genes and the real GECN of HeLa cells based on the cell cycle projection and system identification methods. The strategy to identify common core and specific GECNs between HeLa and ES cells based on big data mining, cell cycle projection, and system identification is summarized in <xref ref-type="fig" rid="f0001">Figure&#160;1</xref>.</p></sec><sec id="s0002-0003"><title>Data retrieval and pre-processing of methylation profiles in both HeLa and ES cells</title><p>To validate the proposed epigenetic regulations, we looked at the genome-wide methylation profile of 307 human cervical cancer cell samples from The Cancer Genome Atlas (TCGA; <ext-link ext-link-type="uri" xlink:href="http://cancergenome.nih.gov/">http://cancergenome.nih.gov/</ext-link>) and 5 human embryonic stem cell lines (GSE24676) from the GEO database.<xref rid="cit0041" ref-type="bibr"><sup>41</sup></xref> By applying one-way ANOVA, we calculated the <italic>p</italic>-value for each gene (or miRNA) and confirmed the significance of expression change between human cervical cancer and ES cells. We used Matlab's text file and string manipulation tools in text mining to unify the gene names based on the gene symbols in the GEO database.</p></sec><sec id="s0002-0004"><title>Cell cycle projection method to determine the cell cycle phase of each gene</title><p>We first applied the cell cycle projection method to the genome-wide raw data of HeLa and ES cells to determine the cell cycle phase of each gene (or miRNA). Based on this, we chose the phase-specific cell cycle genes. Finally, we applied system identification and system order detection methods to the dynamic model of GECN to identify real GECNs.</p><p>In order to determine cell cycle phase of the <italic>i</italic>-th gene (or miRNA), the projection model of cell cycle phase was characterized by the following expression:<disp-formula id="M0001"><label>(1)</label><alternatives><graphic xlink:href="kccy-15-19-1198862-em0001.jpg" position="float" orientation="portrait"/><mml:math id="d27e357"><mml:mrow><mml:msub><mml:mi>x</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mstyle displaystyle="true"><mml:munderover><mml:mo>&#8721;</mml:mo><mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mn>4</mml:mn></mml:munderover><mml:mrow><mml:msub><mml:mi>a</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mi>sin</mml:mi><mml:mtext>&#8201;</mml:mtext><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:mi>&#960;</mml:mi><mml:mi>k</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:mfrac><mml:mo>&#8722;</mml:mo><mml:mfrac><mml:mrow><mml:mn>2</mml:mn><mml:mi>&#960;</mml:mi><mml:mi>t</mml:mi></mml:mrow><mml:mi>T</mml:mi></mml:mfrac></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mi>b</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:mstyle><mml:mo>,</mml:mo><mml:mtext>&#8201;</mml:mtext><mml:mtext>for</mml:mtext><mml:mtext>&#8201;</mml:mtext><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mo>&#8230;</mml:mo><mml:mo>,</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:math></alternatives></disp-formula>where <italic>xi</italic>(0), <italic>xi</italic>(1), <italic>xi</italic>(2), and <italic>xi</italic>(3) denote the expression of the <italic>i</italic>-th gene (or miRNA) during G1, S, G2, and M phases, respectively; the cell cycle period <italic>T</italic> = 4 indicates 4 cell cycle phases; <italic>k</italic> = 1, 2, 3, 4 correspond to G1, S, G2, and M phases, respectively; <italic>ai,k</italic> represents the phase-specific ability of gene <italic>i</italic> during the <italic>k</italic>-th phase; <italic>bi</italic> denotes the basal level of the <italic>i</italic>-th gene (or miRNA); and sin(&#960;/2&#8211;2&#960;<italic>t</italic>/<italic>T</italic>), sin(&#960;&#8211;2&#960;<italic>t</italic>/<italic>T</italic>), sin(3&#960;/2&#8211;2&#960;<italic>t</italic>/<italic>T</italic>), and sin(2&#960;&#8211;2&#960;<italic>t</italic>/<italic>T</italic>) represent the basic functions of G1, S, G2, and M phases, respectively. Equation&#160;(<xref ref-type="disp-formula" rid="M0001">1</xref>) can be scaled up as follows:<disp-formula id="M0002"><label>(2)</label><alternatives><graphic xlink:href="kccy-15-19-1198862-em0002.jpg" position="float" orientation="portrait"/><mml:math id="d27e529"><mml:mtable columnalign="left"><mml:mtr><mml:mtd><mml:msub><mml:mi>X</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:mo minsize="33pt">[</mml:mo><mml:mrow><mml:mtable columnalign="left"><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mi>x</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mi>x</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mi>x</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mn>2</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mi>x</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mn>3</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow><mml:mo minsize="33pt">]</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:mo minsize="60pt">[</mml:mo><mml:mrow><mml:mtable columnalign="left"><mml:mtr><mml:mtd><mml:mrow><mml:mi>sin</mml:mi><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mfrac><mml:mi>&#960;</mml:mi><mml:mn>2</mml:mn></mml:mfrac></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow></mml:mtd><mml:mtd><mml:mrow><mml:mi>sin</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>&#960;</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mtd><mml:mtd><mml:mrow><mml:mi>sin</mml:mi><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:mn>3</mml:mn><mml:mi>&#960;</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:mfrac></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow></mml:mtd><mml:mtd><mml:mrow><mml:mtable columnalign="left"><mml:mtr><mml:mtd><mml:mrow><mml:mi>sin</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mn>2</mml:mn><mml:mi>&#960;</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mtd><mml:mtd><mml:mn>1</mml:mn></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mi>sin</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mn>2</mml:mn><mml:mi>&#960;</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mtd><mml:mtd><mml:mrow><mml:mi>sin</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mfrac><mml:mi>&#960;</mml:mi><mml:mn>2</mml:mn></mml:mfrac><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mtd><mml:mtd><mml:mrow><mml:mi>sin</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>&#960;</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mtd><mml:mtd><mml:mrow><mml:mtable columnalign="left"><mml:mtr><mml:mtd><mml:mrow><mml:mi>sin</mml:mi><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:mn>3</mml:mn><mml:mi>&#960;</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:mfrac></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow></mml:mtd><mml:mtd><mml:mn>1</mml:mn></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mi>sin</mml:mi><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:mn>3</mml:mn><mml:mi>&#960;</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:mfrac></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow></mml:mtd><mml:mtd><mml:mrow><mml:mi>sin</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mn>2</mml:mn><mml:mi>&#960;</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mtd><mml:mtd><mml:mrow><mml:mi>sin</mml:mi><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mfrac><mml:mi>&#960;</mml:mi><mml:mn>2</mml:mn></mml:mfrac></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow></mml:mtd><mml:mtd><mml:mrow><mml:mtable columnalign="left"><mml:mtr><mml:mtd><mml:mrow><mml:mi>sin</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>&#960;</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mtd><mml:mtd><mml:mn>1</mml:mn></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mi>sin</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>&#960;</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mtd><mml:mtd><mml:mrow><mml:mi>sin</mml:mi><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:mn>3</mml:mn><mml:mi>&#960;</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:mfrac></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow></mml:mtd><mml:mtd><mml:mrow><mml:mi>sin</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mn>2</mml:mn><mml:mi>&#960;</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mtd><mml:mtd><mml:mrow><mml:mtable columnalign="left"><mml:mtr><mml:mtd><mml:mrow><mml:mi>sin</mml:mi><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mfrac><mml:mi>&#960;</mml:mi><mml:mn>2</mml:mn></mml:mfrac></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow></mml:mtd><mml:mtd><mml:mn>1</mml:mn></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow><mml:mo minsize="60pt">]</mml:mo></mml:mrow><mml:mrow><mml:mo minsize="47pt">[</mml:mo><mml:mrow><mml:mtable columnalign="left"><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mi>a</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mi>a</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mi>a</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mtable columnalign="left"><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mi>a</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mi>b</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow><mml:mo minsize="47pt">]</mml:mo></mml:mrow></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mo>=</mml:mo><mml:mrow><mml:mo minsize="35pt">[</mml:mo><mml:mrow><mml:mtable columnalign="left"><mml:mtr><mml:mtd><mml:mn>1</mml:mn></mml:mtd><mml:mtd><mml:mn>0</mml:mn></mml:mtd><mml:mtd><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mtd><mml:mtd><mml:mrow><mml:mtable columnalign="left"><mml:mtr><mml:mtd><mml:mn>0</mml:mn></mml:mtd><mml:mtd><mml:mn>1</mml:mn></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mn>0</mml:mn></mml:mtd><mml:mtd><mml:mn>1</mml:mn></mml:mtd><mml:mtd><mml:mn>0</mml:mn></mml:mtd><mml:mtd><mml:mrow><mml:mtable columnalign="left"><mml:mtr><mml:mtd><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mtd><mml:mtd><mml:mn>1</mml:mn></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mtd><mml:mtd><mml:mn>0</mml:mn></mml:mtd><mml:mtd><mml:mn>1</mml:mn></mml:mtd><mml:mtd><mml:mrow><mml:mtable columnalign="left"><mml:mtr><mml:mtd><mml:mn>0</mml:mn></mml:mtd><mml:mtd><mml:mn>1</mml:mn></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mn>0</mml:mn></mml:mtd><mml:mtd><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mtd><mml:mtd><mml:mn>0</mml:mn></mml:mtd><mml:mtd><mml:mrow><mml:mtable columnalign="left"><mml:mtr><mml:mtd><mml:mn>1</mml:mn></mml:mtd><mml:mtd><mml:mn>1</mml:mn></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow><mml:mo minsize="35pt">]</mml:mo></mml:mrow><mml:mrow><mml:mo minsize="47pt">[</mml:mo><mml:mrow><mml:mtable columnalign="left"><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mi>a</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mi>a</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mi>a</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mtable columnalign="left"><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mi>a</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mi>b</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow><mml:mo minsize="47pt">]</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives></disp-formula>where <italic>Xi</italic> denotes the vector of the <italic>i</italic>-th gene (or miRNA) expression during G1, S, G2, and M phases. Accordingly, it was possible to obtain 4 phase-specific abilities for each gene (or miRNA). In order to determine the phase of each gene (or miRNA), we designed the following criterion:<disp-formula id="M0003"><label>(3)</label><alternatives><graphic xlink:href="kccy-15-19-1198862-em0003.jpg" position="float" orientation="portrait"/><mml:math id="d27e1122"><mml:mrow><mml:mtext>gene</mml:mtext><mml:mtext>&#8201;</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mtext>or</mml:mtext><mml:mtext>&#8201;</mml:mtext><mml:mtext>miRNA</mml:mtext><mml:mo stretchy="false">)</mml:mo><mml:mi>i</mml:mi><mml:mo>&#8712;</mml:mo><mml:mtext>phase</mml:mtext><mml:mtext>&#8201;</mml:mtext><mml:msup><mml:mi>k</mml:mi><mml:mo>*</mml:mo></mml:msup><mml:mo>,</mml:mo><mml:mtext>&#8201;</mml:mtext><mml:mtext>for</mml:mtext><mml:mtext>&#8201;</mml:mtext><mml:msup><mml:mi>k</mml:mi><mml:mo>*</mml:mo></mml:msup><mml:mo>=</mml:mo><mml:mi>arg</mml:mi><mml:munder><mml:mrow><mml:mi>max</mml:mi></mml:mrow><mml:mi>k</mml:mi></mml:munder><mml:msub><mml:mi>a</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mtext>&#8201;</mml:mtext><mml:mo>&#160;</mml:mo><mml:mtext>and</mml:mtext><mml:mtext>&#8201;</mml:mtext><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mo>&#8943;</mml:mo><mml:mo>,</mml:mo><mml:mn>4</mml:mn></mml:mrow></mml:math></alternatives></disp-formula>where <italic>ai,k</italic>* denotes the maximal phase-specific ability of the <italic>i</italic>-th gene (or miRNA). Accordingly, the phase criteria in (3) allow us to determine the cell cycle phase of each gene (or miRNA) in the human genome. Moreover, for each gene (or miRNA) we could obtain 12 (4 &#215; 3) phase-specific abilities from 3 biological replicates in HeLa cells. The maximal phase-specific ability of each gene (or miRNA) was used to determine the cell cycle phase. The top 5 most significant phase-specific genes in HeLa and ES cells are shown in <xref ref-type="table" rid="t0001">Table&#160;1</xref>. Furthermore, we defined an upper threshold (&#8805; <italic>a</italic><sub><italic>th</italic></sub>) of the phase-specific ability to choose the significant cell cycle genes. Tables&#160;S1 and S2 show 303 cell cycle genes (<italic>a</italic><sub><italic>th</italic></sub> = 0.2) in HeLa cells and 299 cell cycle genes (<italic>a</italic><sub><italic>th</italic></sub> = 5.2) in ESCs. These genes were validated by taking into account their expression Z scores (<xref ref-type="fig" rid="f0002">Fig.&#160;2A and B</xref>, respectively).
<fig id="f0002" orientation="portrait" position="float"><label>Figure 2.</label><caption><p>Identification of HeLa and ESC cell cycle genes after applying the cell cycle projection method. HeLa and ES cells cell cycle genes were selected according to the maximal phase-specific ability value, i.e., <italic>ai,k</italic>* in (3). The right bar represents the Z score, from maximum (white) to minimum value (black). The phase-shift of cell cycle genes can be observed as white blocks along the diagonal.</p></caption><graphic xlink:href="kccy-15-19-1198862-g002"/></fig>
<table-wrap id="t0001" orientation="portrait" position="float"><label>Table 1.</label><caption><p>Top 5 phase-specific genes in HeLa and ES cells.A complete list of identified cell cycle genes in HeLa cells (303) and ESCs (299) can be found in Tables&#160;S1 and S2, respectively.</p></caption><!--OASIS TABLE HERE--></table-wrap>
</p></sec><sec id="s0002-0005"><title>Construction of candidate GECN by the big database mining method</title><p>In order to construct the candidate GECN of human cells, including transcription and miRNA regulation during cell cycle progression, we mined the integrated information from the big database. This encompassed TF-gene association data from the Integrated Transcription Factor Platform (ITFP),<xref rid="cit0042" ref-type="bibr"><sup>42</sup></xref> the Human Transcriptional Regulation Interactions database (HTRIdb),<xref rid="cit0043" ref-type="bibr"><sup>43</sup></xref> the TRANScription FACtor (TRANSFAC) database,<xref rid="cit0044" ref-type="bibr"><sup>44</sup></xref> and miRNA-target association data from TargetScan.<xref rid="cit0045" ref-type="bibr"><sup>45</sup></xref> TF-gene association and miRNA-target association data provided 152,828 and 2,477 candidate associations, respectively, including experimental and computational results. To evaluate each association and prune false positives we applied system identification and system order detection methods to the dynamic model of candidate GECN (see below).</p></sec><sec id="s0002-0006"><title>Construction of the dynamic model in candidate GECN by big database mining</title><p>To identify regulation mechanisms in the candidate GECN, we constructed a dynamic model of the GECN in human cells. The latter characterized the transcription and miRNA regulation of the <italic>i</italic>-th cell cycle gene by the stochastic discrete equation as follows:<disp-formula id="M0004"><label>(4)</label><alternatives><graphic xlink:href="kccy-15-19-1198862-em0004.jpg" position="float" orientation="portrait"/><mml:math id="d27e1496"><mml:mrow><mml:msub><mml:mi>x</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">[</mml:mo><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">]</mml:mo><mml:mo>=</mml:mo><mml:msub><mml:mi>x</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">[</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">]</mml:mo><mml:mo>+</mml:mo><mml:mstyle displaystyle="true"><mml:munderover><mml:mo>&#8721;</mml:mo><mml:mrow><mml:mi>m</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:msubsup><mml:mi>M</mml:mi><mml:mi>i</mml:mi><mml:mrow><mml:mi>T</mml:mi><mml:mi>F</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:munderover><mml:mrow><mml:msub><mml:mi>a</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>m</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>y</mml:mi><mml:mi>m</mml:mi></mml:msub><mml:mo stretchy="false">[</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">]</mml:mo><mml:mo>&#8722;</mml:mo></mml:mrow></mml:mstyle><mml:mstyle displaystyle="true"><mml:munderover><mml:mo>&#8721;</mml:mo><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:msubsup><mml:mi>N</mml:mi><mml:mi>i</mml:mi><mml:mrow><mml:mi>M</mml:mi><mml:mi>I</mml:mi><mml:mi>R</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:munderover><mml:mrow><mml:msub><mml:mi>b</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>z</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mo stretchy="false">[</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:mstyle><mml:mo>&#8722;</mml:mo><mml:msub><mml:mi>&#955;</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:msub><mml:mi>x</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">[</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">]</mml:mo><mml:mo>+</mml:mo><mml:msub><mml:mi>&#954;</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>v</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">[</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">]</mml:mo><mml:mtext>&#8201;</mml:mtext><mml:mo>,</mml:mo><mml:mtext>&#8201;</mml:mtext><mml:mtext>for</mml:mtext><mml:mtext>&#8201;</mml:mtext><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mo>&#8230;</mml:mo><mml:mo>,</mml:mo><mml:mi>M</mml:mi></mml:mrow></mml:math></alternatives></disp-formula>where <italic>x</italic><sub><italic>i</italic></sub>[<italic>t</italic>], <italic>y</italic><sub><italic>m</italic></sub>[<italic>t</italic>], and <italic>z</italic><sub><italic>n</italic></sub>[<italic>t</italic>] denote the <italic>i</italic>-th gene, the <italic>m</italic>-th TF, and the <italic>n</italic>-th miRNA expressions at time <italic>t</italic>, respectively; <italic>a</italic><sub><italic>im</italic></sub> and -<italic>b</italic><sub><italic>in</italic></sub> indicate the regulatory abilities of the <italic>m</italic>-th TF and the <italic>n</italic>-th miRNA to the <italic>i</italic>-th target gene (-<italic>b</italic><sub><italic>in</italic></sub> &#8804; 0), respectively; <italic>MTF I</italic> and <italic>NMIR I</italic> are the numbers of candidate TF and miRNA associations with cell cycle gene <italic>i</italic> obtained from the constructed candidate GECN, respectively; <italic>M</italic> represents the number of cell cycle genes identified by the cell cycle projection method; -&#955;<sub><italic>i</italic></sub> denotes the degradation effect of the present state on the next state (-&#955;<sub><italic>i</italic></sub> &#8804; 0); &#954;<sub><italic>i</italic></sub> is the basal level of target gene <italic>i</italic> (&#954;<sub><italic>i</italic></sub> &#8805; 0); and <italic>v</italic><sub><italic>i</italic></sub>[<italic>t</italic>] represents the stochastic noise due to model uncertainty and fluctuation.</p><p>The biological meaning of (<xref ref-type="disp-formula" rid="M0004">4</xref>) is that the mRNA expression level of the cell cycle gene <italic>i</italic> at time <italic>t+</italic>1 is affected by its own mRNA expression level at time <italic>t</italic>, the transcription level regulation from the associated TFs <inline-formula><alternatives><inline-graphic xlink:href="kccy-15-19-1198862-eilm0001.jpg"/><mml:math id="d27e1810"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mstyle displaystyle="false"><mml:msubsup><mml:mo>&#8721;</mml:mo><mml:mrow><mml:mi>m</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:msubsup><mml:mi>M</mml:mi><mml:mi>i</mml:mi><mml:mrow><mml:mi>T</mml:mi><mml:mi>F</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:msubsup><mml:mrow><mml:msub><mml:mi>a</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>m</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>y</mml:mi><mml:mi>m</mml:mi></mml:msub><mml:mo stretchy="false">[</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">]</mml:mo><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mstyle></mml:mrow></mml:math></alternatives></inline-formula>, the repression exerted by associated miRNAs <inline-formula><alternatives><inline-graphic xlink:href="kccy-15-19-1198862-eilm0002.jpg"/><mml:math id="d27e1863"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mo>&#8722;</mml:mo><mml:mstyle displaystyle="false"><mml:msubsup><mml:mo>&#8721;</mml:mo><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:msubsup><mml:mi>N</mml:mi><mml:mi>i</mml:mi><mml:mrow><mml:mi>M</mml:mi><mml:mi>I</mml:mi><mml:mi>R</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:msubsup><mml:mrow><mml:msub><mml:mi>b</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>z</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mo stretchy="false">[</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:mstyle><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>, its own degradation effect (-&#955;<sub><italic>i</italic></sub><italic>x</italic><sub><italic>i</italic></sub>[<italic>t</italic>]) at time <italic>t</italic>, the basal level <inline-formula><alternatives><inline-graphic xlink:href="kccy-15-19-1198862-eilm0003.jpg"/><mml:math id="d27e1934"><mml:mrow><mml:msub><mml:mi>&#954;</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:math></alternatives></inline-formula> from other sources, such as DNA methylation and histone modification among others. We assumed that the basal level <inline-formula><alternatives><inline-graphic xlink:href="kccy-15-19-1198862-eilm0004.jpg"/><mml:math id="d27e1946"><mml:mstyle displaystyle="true"><mml:mrow><mml:msub><mml:mi>&#954;</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:mstyle></mml:math></alternatives></inline-formula> change of the <italic>i</italic>-th gene between 2 cells determined the epigenetic alterations of gene <italic>i</italic>. Considering that large-scale measurement of protein activity has yet to be realized and 73% of the variance in protein abundance can be explained by mRNA abundance,<xref rid="cit0046" ref-type="bibr"><sup>46</sup></xref> we employed mRNA expression profiles in lieu of protein expression profiles.</p></sec><sec id="s0002-0007"><title>Identification of the real GECN by pruning false positives in candidate GECN via the akaike information criterion (AIC) system order detection method</title><p>After constructing the dynamic model of GECN in (<xref ref-type="disp-formula" rid="M0004">4</xref>), we applied the system identification and system order detection methods to the model to prune the false-positive associations in HeLa (or ES) cells using their corresponding cell cycle expression data. To identify the regulatory parameters in (<xref ref-type="disp-formula" rid="M0004">4</xref>), i.e., <italic>a</italic><sub><italic>im</italic></sub> and <italic>b</italic><sub><italic>in</italic></sub>, we rewrote the stochastic dynamic model in (<xref ref-type="disp-formula" rid="M0004">4</xref>) as the following stochastic linear regression form:<disp-formula id="M0005"><label>(5)</label><alternatives><graphic xlink:href="kccy-15-19-1198862-em0005.jpg" position="float" orientation="portrait"/><mml:math id="d27e1997"><mml:mtable columnalign="left"><mml:mtr><mml:mtd><mml:msub><mml:mi>x</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">[</mml:mo><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">]</mml:mo><mml:mtext>&#160;</mml:mtext></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mo>=</mml:mo><mml:mrow><mml:mo minsize="12pt">[</mml:mo><mml:mrow><mml:mtable columnalign="left"><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mi>y</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo stretchy="false">[</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:mtd><mml:mtd><mml:mo>&#8943;</mml:mo></mml:mtd><mml:mtd><mml:mrow><mml:msub><mml:mi>y</mml:mi><mml:mrow><mml:msubsup><mml:mi>M</mml:mi><mml:mi>i</mml:mi><mml:mrow><mml:mi>T</mml:mi><mml:mi>F</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:msub><mml:mo stretchy="false">[</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:mtd><mml:mtd><mml:mrow><mml:msub><mml:mi>z</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo stretchy="false">[</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:mtd><mml:mtd><mml:mo>&#8943;</mml:mo></mml:mtd><mml:mtd><mml:mrow><mml:msub><mml:mi>z</mml:mi><mml:mrow><mml:msubsup><mml:mi>N</mml:mi><mml:mi>i</mml:mi><mml:mrow><mml:mi>M</mml:mi><mml:mi>I</mml:mi><mml:mi>R</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:msub><mml:mo stretchy="false">[</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:mtd><mml:mtd><mml:mrow><mml:msub><mml:mi>x</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">[</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:mtd><mml:mtd><mml:mn>1</mml:mn></mml:mtd></mml:mtr></mml:mtable></mml:mrow><mml:mo minsize="12pt">]</mml:mo></mml:mrow><mml:mrow><mml:mo minsize="80pt">[</mml:mo><mml:mrow><mml:mtable columnalign="left"><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mi>a</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mo>&#8942;</mml:mo></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mi>a</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:msubsup><mml:mi>M</mml:mi><mml:mi>i</mml:mi><mml:mrow><mml:mi>T</mml:mi><mml:mi>F</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mo>&#8722;</mml:mo><mml:msub><mml:mi>b</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mo>&#8942;</mml:mo></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mo>&#8722;</mml:mo><mml:msub><mml:mi>b</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:msubsup><mml:mi>N</mml:mi><mml:mi>i</mml:mi><mml:mrow><mml:mi>M</mml:mi><mml:mi>I</mml:mi><mml:mi>R</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mn>1</mml:mn><mml:mo>&#8722;</mml:mo><mml:msub><mml:mi>&#955;</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mi>&#954;</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow><mml:mo minsize="80pt">]</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mtext>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</mml:mtext><mml:mo>+</mml:mo><mml:msub><mml:mi>v</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">[</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">]</mml:mo><mml:mo>=</mml:mo><mml:msub><mml:mi>&#981;</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">[</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">]</mml:mo><mml:msub><mml:mi>&#952;</mml:mi><mml:mtext>i</mml:mtext></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>v</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">[</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">]</mml:mo><mml:mo>,</mml:mo></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mtext>Subject&#160;to&#160;</mml:mtext><mml:mover><mml:mover><mml:mrow><mml:mrow><mml:mo minsize="46pt">[</mml:mo><mml:mrow><mml:mtable columnalign="left"><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mn>0</mml:mn></mml:mtd><mml:mtd columnalign="left"><mml:mo>&#8943;</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mn>0</mml:mn></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mo>&#8942;</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mo>&#8945;</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mo>&#8942;</mml:mo></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mn>0</mml:mn></mml:mtd><mml:mtd columnalign="left"><mml:mo>&#8943;</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mn>0</mml:mn></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mn>0</mml:mn></mml:mtd><mml:mtd columnalign="left"><mml:mo>&#8943;</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mo>&#8943;</mml:mo></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mn>0</mml:mn></mml:mtd><mml:mtd columnalign="left"><mml:mo>&#8943;</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mo>&#8943;</mml:mo></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mrow></mml:mrow><mml:mo stretchy="true">&#65079;</mml:mo></mml:mover><mml:mrow><mml:msubsup><mml:mi>M</mml:mi><mml:mi>i</mml:mi><mml:mrow><mml:mi>T</mml:mi><mml:mi>F</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:mover><mml:mover><mml:mover><mml:mrow><mml:mtable columnalign="left"><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mn>1</mml:mn></mml:mtd><mml:mtd columnalign="left"><mml:mn>0</mml:mn></mml:mtd><mml:mtd columnalign="left"><mml:mn>0</mml:mn></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mn>0</mml:mn></mml:mtd><mml:mtd columnalign="left"><mml:mo>&#8945;</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mn>0</mml:mn></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mn>0</mml:mn></mml:mtd><mml:mtd columnalign="left"><mml:mn>0</mml:mn></mml:mtd><mml:mtd columnalign="left"><mml:mn>1</mml:mn></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mo>&#8943;</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mo>&#8943;</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mn>0</mml:mn></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mo>&#8943;</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mo>&#8943;</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mn>0</mml:mn></mml:mtd></mml:mtr></mml:mtable></mml:mrow><mml:mo stretchy="true">&#65079;</mml:mo></mml:mover><mml:mrow><mml:msubsup><mml:mi>N</mml:mi><mml:mi>i</mml:mi><mml:mrow><mml:mi>M</mml:mi><mml:mi>I</mml:mi><mml:mi>R</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:mover><mml:mrow><mml:mrow><mml:mtable columnalign="left"><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mn>0</mml:mn></mml:mtd><mml:mtd columnalign="left"><mml:mn>0</mml:mn></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mo>&#8942;</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mo>&#8942;</mml:mo></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mn>0</mml:mn></mml:mtd><mml:mtd columnalign="left"><mml:mn>0</mml:mn></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mn>1</mml:mn></mml:mtd><mml:mtd columnalign="left"><mml:mn>0</mml:mn></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mn>0</mml:mn></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow><mml:mo minsize="46pt">]</mml:mo></mml:mrow><mml:msub><mml:mi>&#952;</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>&#8804;</mml:mo><mml:mrow><mml:mo minsize="50pt">[</mml:mo><mml:mrow><mml:mtable columnalign="left"><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mn>0</mml:mn></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mo>&#8942;</mml:mo></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mn>0</mml:mn></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mn>1</mml:mn></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mn>0</mml:mn></mml:mtd></mml:mtr></mml:mtable></mml:mrow><mml:mo minsize="50pt">]</mml:mo></mml:mrow><mml:mo>,</mml:mo><mml:mtext>&#160;</mml:mtext><mml:mo>&#8704;</mml:mo><mml:mi>i</mml:mi></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives></disp-formula>where &#981;<sub><italic>i</italic></sub>[<italic>t</italic>] denotes the regression vector of target gene <italic>i</italic>; &#981;<sub><italic>i</italic></sub>[<italic>t</italic>] and <italic>x</italic><sub><italic>i</italic></sub>[<italic>t</italic>+1] can be obtained from the gene (or miRNA) expression data; and &#952;<sub><italic>i</italic></sub> indicates the parameter vector of the cell cycle gene <italic>i</italic> to be estimated. Moreover, taking the cubic spline method to interpolate expression data can effectively prevent parameter overfitting in the parameter estimation process. The inequality constraint in (<xref ref-type="disp-formula" rid="M0005">5</xref>) guarantees that -&#955;<sub><italic>i</italic></sub> &#8804; 0, -<italic>b</italic><sub><italic>in</italic></sub> &#8804; 0 and &#954;<sub><italic>i</italic></sub> &#8805; 0.</p><p>Furthermore, the stochastic linear regression equation&#160;(<xref ref-type="disp-formula" rid="M0005">5</xref>) can be scaled up along each time point as the following form:<disp-formula id="M0006"><label>(6)</label><alternatives><graphic xlink:href="kccy-15-19-1198862-em0006.jpg" position="float" orientation="portrait"/><mml:math id="d27e2568"><mml:mrow><mml:mrow><mml:mo minsize="49pt">[</mml:mo><mml:mrow><mml:mtable columnalign="left"><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:msub><mml:mi>x</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">[</mml:mo><mml:mn>2</mml:mn><mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mo>&#8942;</mml:mo></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:msub><mml:mi>x</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">[</mml:mo><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mo>&#8942;</mml:mo></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:msub><mml:mi>x</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">[</mml:mo><mml:mi>T</mml:mi><mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow><mml:mo minsize="49pt">]</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:mo minsize="49pt">[</mml:mo><mml:mrow><mml:mtable columnalign="left"><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:msub><mml:mi>&#981;</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">[</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mo>&#8942;</mml:mo></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:msub><mml:mi>&#981;</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">[</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mo>&#8942;</mml:mo></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:msub><mml:mi>&#981;</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">[</mml:mo><mml:mi>T</mml:mi><mml:mo>&#8722;</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow><mml:mo minsize="49pt">]</mml:mo></mml:mrow><mml:msub><mml:mi>&#952;</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:mrow><mml:mo minsize="55pt">[</mml:mo><mml:mrow><mml:mtable columnalign="left"><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:msub><mml:mi>v</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">[</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mo>&#8942;</mml:mo></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:msub><mml:mi>v</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">[</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mo>&#8942;</mml:mo></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:msub><mml:mi>v</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">[</mml:mo><mml:mi>T</mml:mi><mml:mo>&#8722;</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow><mml:mo minsize="55pt">]</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></disp-formula>where <italic>T</italic> denotes the number of expression data time points after using the cubic spline interpolation method.</p><p>For convenience, (<xref ref-type="disp-formula" rid="M0006">6</xref>) is represented by the following equation:<disp-formula id="M0007"><label>(7)</label><alternatives><graphic xlink:href="kccy-15-19-1198862-em0007.jpg" position="float" orientation="portrait"/><mml:math id="d27e2776"><mml:mrow><mml:msub><mml:mi>X</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>&#934;</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:msub><mml:mi>&#952;</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>V</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:math></alternatives></disp-formula></p><p>The constrained least square estimation problem in (<xref ref-type="disp-formula" rid="M0005">5</xref>) or (<xref ref-type="disp-formula" rid="M0007">7</xref>) relating to the parameter vector of the target gene <italic>i</italic> was formulated as follows:<disp-formula id="M0008"><label>(8)</label><alternatives><graphic xlink:href="kccy-15-19-1198862-em0008.jpg" position="float" orientation="portrait"/><mml:math id="d27e2818"><mml:mtable columnalign="left"><mml:mtr><mml:mtd><mml:munder><mml:mrow><mml:mi>min</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mi>&#952;</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:munder><mml:mfrac><mml:mn>1</mml:mn><mml:mn>2</mml:mn></mml:mfrac><mml:msup><mml:mrow><mml:mo>&#8214;</mml:mo><mml:mrow><mml:msub><mml:mi>&#934;</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:msub><mml:mi>&#952;</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>&#8722;</mml:mo><mml:msub><mml:mi>X</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow><mml:mo>&#8214;</mml:mo></mml:mrow><mml:mtext>2</mml:mtext></mml:msup></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mtext>Subject&#160;to</mml:mtext><mml:mtext>&#8201;</mml:mtext><mml:mover><mml:mover><mml:mrow><mml:mrow><mml:mo minsize="45pt">[</mml:mo><mml:mrow><mml:mtable columnalign="left"><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mn>0</mml:mn></mml:mtd><mml:mtd columnalign="left"><mml:mo>&#8943;</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mn>0</mml:mn></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mo>&#8942;</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mo>&#8945;</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mo>&#8942;</mml:mo></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mn>0</mml:mn></mml:mtd><mml:mtd columnalign="left"><mml:mo>&#8943;</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mn>0</mml:mn></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mn>0</mml:mn></mml:mtd><mml:mtd columnalign="left"><mml:mo>&#8943;</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mo>&#8943;</mml:mo></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mn>0</mml:mn></mml:mtd><mml:mtd columnalign="left"><mml:mo>&#8943;</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mo>&#8943;</mml:mo></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mrow></mml:mrow><mml:mo stretchy="true">&#65079;</mml:mo></mml:mover><mml:mrow><mml:msubsup><mml:mi>M</mml:mi><mml:mi>i</mml:mi><mml:mrow><mml:mi>T</mml:mi><mml:mi>F</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:mover><mml:mover><mml:mover><mml:mrow><mml:mtable columnalign="left"><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mn>1</mml:mn></mml:mtd><mml:mtd columnalign="left"><mml:mn>0</mml:mn></mml:mtd><mml:mtd columnalign="left"><mml:mn>0</mml:mn></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mn>0</mml:mn></mml:mtd><mml:mtd columnalign="left"><mml:mo>&#8945;</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mn>0</mml:mn></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mn>0</mml:mn></mml:mtd><mml:mtd columnalign="left"><mml:mn>0</mml:mn></mml:mtd><mml:mtd columnalign="left"><mml:mn>1</mml:mn></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mo>&#8943;</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mo>&#8943;</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mn>0</mml:mn></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mo>&#8943;</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mo>&#8943;</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mn>0</mml:mn></mml:mtd></mml:mtr></mml:mtable></mml:mrow><mml:mo stretchy="true">&#65079;</mml:mo></mml:mover><mml:mrow><mml:msubsup><mml:mi>N</mml:mi><mml:mi>i</mml:mi><mml:mrow><mml:mi>M</mml:mi><mml:mi>I</mml:mi><mml:mi>R</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:mover><mml:mrow><mml:mrow><mml:mtable columnalign="left"><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mn>0</mml:mn></mml:mtd><mml:mtd columnalign="left"><mml:mn>0</mml:mn></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mo>&#8942;</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mo>&#8942;</mml:mo></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mn>0</mml:mn></mml:mtd><mml:mtd columnalign="left"><mml:mn>0</mml:mn></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mn>1</mml:mn></mml:mtd><mml:mtd columnalign="left"><mml:mn>0</mml:mn></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mn>0</mml:mn></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow><mml:mo minsize="45pt">]</mml:mo></mml:mrow><mml:msub><mml:mi>&#952;</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>&#8804;</mml:mo><mml:mrow><mml:mo minsize="49pt">[</mml:mo><mml:mrow><mml:mtable columnalign="left"><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mn>0</mml:mn></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mo>&#8942;</mml:mo></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mn>0</mml:mn></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mn>1</mml:mn></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mn>0</mml:mn></mml:mtd></mml:mtr></mml:mtable></mml:mrow><mml:mo minsize="49pt">]</mml:mo></mml:mrow><mml:mo>,</mml:mo><mml:mtext>&#160;</mml:mtext><mml:mo>&#8704;</mml:mo><mml:mi>i</mml:mi></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives></disp-formula></p><p>The problem in (<xref ref-type="disp-formula" rid="M0008">8</xref>) can be optimized using the constrained least-square solver based on a reflective Newton method for minimizing a quadratic function to identify the parameter &#952;<sub><italic>i</italic></sub> using the MATLAB optimization toolbox.<xref rid="cit0047" ref-type="bibr"><sup>47</sup></xref></p><p>When the regulatory parameters in the candidate GECN could be identified by solving the problem in (<xref ref-type="disp-formula" rid="M0008">8</xref>) one gene at a time, we applied AIC <xref rid="cit0048" ref-type="bibr"><sup>48</sup></xref> as a system order detection method to prune false-positive regulations from the candidate GECN. AIC can simultaneously consider the estimated residual error and model complexity, and it can estimate the system order of the dynamic model (i.e., the number of regulations <italic>MTF i+ NMIRi</italic> in this case). For a stochastic discrete equation in (<xref ref-type="disp-formula" rid="M0004">4</xref>) with <italic>MTF i+ NMIRi</italic> regulatory parameters, AIC could be written as follows:<disp-formula id="M0009"><label>(9)</label><alternatives><graphic xlink:href="kccy-15-19-1198862-em0009.jpg" position="float" orientation="portrait"/><mml:math id="d27e3131"><mml:mrow><mml:mi>A</mml:mi><mml:mi>I</mml:mi><mml:mi>C</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:msubsup><mml:mi>N</mml:mi><mml:mi>i</mml:mi><mml:mrow><mml:mi>T</mml:mi><mml:mi>F</mml:mi></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:msubsup><mml:mi>N</mml:mi><mml:mi>i</mml:mi><mml:mrow><mml:mi>M</mml:mi><mml:mi>I</mml:mi><mml:mi>R</mml:mi></mml:mrow></mml:msubsup><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mi>log</mml:mi><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mfrac><mml:mn>1</mml:mn><mml:mi>T</mml:mi></mml:mfrac><mml:msup><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>X</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>&#8722;</mml:mo><mml:msub><mml:mover accent="true"><mml:mi>X</mml:mi><mml:mo>^</mml:mo></mml:mover><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mi>T</mml:mi></mml:msup><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>X</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>&#8722;</mml:mo><mml:msub><mml:mover accent="true"><mml:mi>X</mml:mi><mml:mo>^</mml:mo></mml:mover><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:mn>2</mml:mn><mml:mo stretchy="false">(</mml:mo><mml:msubsup><mml:mi>M</mml:mi><mml:mi>i</mml:mi><mml:mrow><mml:mi>T</mml:mi><mml:mi>F</mml:mi></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:msubsup><mml:mi>N</mml:mi><mml:mi>i</mml:mi><mml:mrow><mml:mi>M</mml:mi><mml:mi>I</mml:mi><mml:mi>R</mml:mi></mml:mrow></mml:msubsup><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mi>T</mml:mi></mml:mfrac></mml:mrow></mml:math></alternatives></disp-formula>where <inline-formula><alternatives><inline-graphic xlink:href="kccy-15-19-1198862-eilm0005.jpg"/><mml:math id="d27e3265"><mml:mstyle displaystyle="true"><mml:mrow><mml:msub><mml:mover accent="true"><mml:mi>X</mml:mi><mml:mo>^</mml:mo></mml:mover><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:mstyle></mml:math></alternatives></inline-formula> denotes the estimated expression of the <italic>i</italic>-th target gene, i.e., <inline-formula><alternatives><inline-graphic xlink:href="kccy-15-19-1198862-eilm0006.jpg"/><mml:math id="d27e3283"><mml:mrow><mml:msub><mml:mover accent="true"><mml:mi>X</mml:mi><mml:mo>^</mml:mo></mml:mover><mml:mi>i</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>&#934;</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:msub><mml:mover accent="true"><mml:mi>&#952;</mml:mi><mml:mo>^</mml:mo></mml:mover><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>, and the estimated residual error <inline-formula><alternatives><inline-graphic xlink:href="kccy-15-19-1198862-eilm0007.jpg"/><mml:math id="d27e3312"><mml:mstyle displaystyle="true"><mml:mrow><mml:msubsup><mml:mover accent="true"><mml:mi>&#963;</mml:mi><mml:mo>^</mml:mo></mml:mover><mml:mi>i</mml:mi><mml:mn>2</mml:mn></mml:msubsup><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>X</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>&#8722;</mml:mo><mml:msub><mml:mover accent="true"><mml:mi>X</mml:mi><mml:mo>^</mml:mo></mml:mover><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mi>T</mml:mi></mml:msup><mml:mtext>&#8201;</mml:mtext><mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>X</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>&#8722;</mml:mo><mml:msub><mml:mover accent="true"><mml:mi>X</mml:mi><mml:mo>^</mml:mo></mml:mover><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>/</mml:mo><mml:mi>T</mml:mi></mml:mrow></mml:mrow></mml:mstyle></mml:math></alternatives></inline-formula>. As the residual error <inline-formula><alternatives><inline-graphic xlink:href="kccy-15-19-1198862-eilm0008.jpg"/><mml:math id="d27e3381"><mml:mstyle displaystyle="true"><mml:mrow><mml:msubsup><mml:mover accent="true"><mml:mi>&#963;</mml:mi><mml:mo>^</mml:mo></mml:mover><mml:mi>i</mml:mi><mml:mn>2</mml:mn></mml:msubsup></mml:mrow></mml:mstyle></mml:math></alternatives></inline-formula> decreases, AIC decreases. In contrast, the number of TF and miRNA regulations, i.e., <italic>MTF i+ NMIRi</italic>, increases and AIC increases. Therefore, AIC constitutes a trade-off between residual error and model order, and will achieve the minimum at the true order, i.e., the true regulation number. If <italic>AIC</italic> in (<xref ref-type="disp-formula" rid="M0009">9</xref>) were minimized, the real GECN <xref rid="cit0048" ref-type="bibr"><sup>48</sup></xref> could be obtained by deleting insignificant TF and miRNA regulations (i.e., the so-called false-positive regulations) out of the true regulations identified by AIC. In addition, Student's <italic>t</italic>-test was applied to calculate the <italic>p</italic>-value of each regulation parameter under the null hypothesis <italic>H</italic><sub><italic>0</italic></sub>: <italic>a</italic><sub><italic>im</italic></sub> = 0 or <italic>H</italic><sub><italic>0</italic></sub>: <italic>b</italic><sub><italic>in</italic></sub>= 0.<xref rid="cit0049" ref-type="bibr"><sup>49</sup></xref></p><p>By applying the regulation parameter estimation in (<xref ref-type="disp-formula" rid="M0008">8</xref>) and the false-positive regulation deletion using AIC in (<xref ref-type="disp-formula" rid="M0009">9</xref>) one gene at a time, we could identify the real GECNs of HeLa and ES cells in each cell cycle phase (<xref ref-type="fig" rid="f0003">Fig.&#160;3A and B</xref>, respectively) from a candidate GECN using the classified high-throughput expression data in each cell cycle phase of HeLa and ES cells, respectively.
<fig id="f0003" orientation="portrait" position="float"><label>Figure 3.</label><caption><p>Real GECNs of HeLa and ES cells. The number of G1 and S phase TFs and genes, and G2 phase TFs decreased significantly in HeLa compared to that in ES cells; whereas the number of M phase TFs and genes increased significantly. In addition, the numbers of G1, S, and G2 phase TF regulations in HeLa cells also decreased compared to ES cells; whereas the number of M phase TF regulations increased. These results support the immortal nature of HeLa cells being due to dysregulation of genes at the G1/G2 checkpoint and cell cycle exit.</p></caption><graphic xlink:href="kccy-15-19-1198862-g003"/></fig>
</p></sec><sec id="s0002-0008"><title>Identification of core GECNs in the real GECNs of HeLa and ES cells for the investigation of carcinogenic and stemness mechanisms and multiple drug design via PGNP</title><p>To investigate the carcinogenic and stemness mechanisms in cervical cancer and ES cells, respectively, we applied PGNP to the real GECNs (<xref ref-type="fig" rid="f0003">Fig.&#160;3</xref>) to extract the core GECNs. This included specific GECNs in HeLa and ES cells, and common core GECN between the 2 cell types. The extracted specific GECNs in HeLa cells were regarded as a cervical cancer-specific network and the principal regulatory network in the real GECN of HeLa cells, which should be useful for multiple drug design of cervical cancer. A PGNP approach based on singular value decomposition <xref rid="cit0050" ref-type="bibr"><sup>50</sup></xref> was used for the extraction of principal network structure and reduction of network dimension. First, the regulation matrix <italic>R</italic> of GECNs, consisting of the regulatory parameters in (<xref ref-type="disp-formula" rid="M0004">4</xref>), i.e., <italic>a</italic><sub><italic>im</italic></sub> and <italic>b</italic><sub><italic>in</italic></sub>, was set as follows:<disp-formula id="M0010"><label>(10)</label><alternatives><graphic xlink:href="kccy-15-19-1198862-em0010.jpg" position="float" orientation="portrait"/><mml:math id="d27e3499"><mml:mrow><mml:mi>R</mml:mi><mml:mo>=</mml:mo><mml:mrow><mml:mo minsize="26pt">[</mml:mo><mml:mrow><mml:mtable columnalign="left"><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mi>a</mml:mi><mml:mrow><mml:mn>11</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mtd><mml:mtd><mml:mo>&#8943;</mml:mo></mml:mtd><mml:mtd><mml:mrow><mml:msub><mml:mi>a</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:msup><mml:mi>M</mml:mi><mml:mrow><mml:mi>T</mml:mi><mml:mi>F</mml:mi></mml:mrow></mml:msup></mml:mrow></mml:msub></mml:mrow></mml:mtd><mml:mtd><mml:mrow><mml:mo>&#8722;</mml:mo><mml:msub><mml:mi>b</mml:mi><mml:mrow><mml:mn>11</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mtd><mml:mtd><mml:mo>&#8943;</mml:mo></mml:mtd><mml:mtd><mml:mrow><mml:mo>&#8722;</mml:mo><mml:msub><mml:mi>b</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:msup><mml:mi>N</mml:mi><mml:mrow><mml:mi>M</mml:mi><mml:mi>I</mml:mi><mml:mi>R</mml:mi></mml:mrow></mml:msup></mml:mrow></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mo>&#8942;</mml:mo></mml:mtd><mml:mtd><mml:mo>&#8945;</mml:mo></mml:mtd><mml:mtd><mml:mo>&#8942;</mml:mo></mml:mtd><mml:mtd><mml:mo>&#8942;</mml:mo></mml:mtd><mml:mtd><mml:mo>&#8945;</mml:mo></mml:mtd><mml:mtd><mml:mo>&#8942;</mml:mo></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mi>a</mml:mi><mml:mrow><mml:mi>M</mml:mi><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mtd><mml:mtd><mml:mo>&#8943;</mml:mo></mml:mtd><mml:mtd><mml:mrow><mml:msub><mml:mi>a</mml:mi><mml:mrow><mml:mi>M</mml:mi><mml:msup><mml:mi>M</mml:mi><mml:mrow><mml:mi>T</mml:mi><mml:mi>F</mml:mi></mml:mrow></mml:msup></mml:mrow></mml:msub></mml:mrow></mml:mtd><mml:mtd><mml:mrow><mml:mo>&#8722;</mml:mo><mml:msub><mml:mi>b</mml:mi><mml:mrow><mml:mi>M</mml:mi><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mtd><mml:mtd><mml:mo>&#8943;</mml:mo></mml:mtd><mml:mtd><mml:mrow><mml:mo>&#8722;</mml:mo><mml:msub><mml:mi>b</mml:mi><mml:mrow><mml:mi>M</mml:mi><mml:msup><mml:mi>N</mml:mi><mml:mrow><mml:mi>M</mml:mi><mml:mi>I</mml:mi><mml:mi>R</mml:mi></mml:mrow></mml:msup></mml:mrow></mml:msub></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow><mml:mo minsize="26pt">]</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></disp-formula></p><p>The regulation matrix <italic>R</italic> can be decomposed by singular value decomposition method as follows <xref rid="cit0050" ref-type="bibr"><sup>50</sup></xref>:<disp-formula id="M0011"><label>(11)</label><alternatives><graphic xlink:href="kccy-15-19-1198862-em0011.jpg" position="float" orientation="portrait"/><mml:math id="d27e3671"><mml:mrow><mml:mi>R</mml:mi><mml:mo>=</mml:mo><mml:mi>U</mml:mi><mml:mo>&#8721;</mml:mo><mml:msup><mml:mi>V</mml:mi><mml:mi>T</mml:mi></mml:msup></mml:mrow></mml:math></alternatives></disp-formula>where the orthogonal matrices <inline-formula><alternatives><inline-graphic xlink:href="kccy-15-19-1198862-eilm0009.jpg"/><mml:math id="d27e3690"><mml:mrow><mml:mi>U</mml:mi><mml:mo>&#8712;</mml:mo><mml:msup><mml:mi>&#8477;</mml:mi><mml:mrow><mml:mtext>M</mml:mtext><mml:mo>&#215;</mml:mo><mml:mi>M</mml:mi></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula> and <inline-formula><alternatives><inline-graphic xlink:href="kccy-15-19-1198862-eilm0010.jpg"/><mml:math id="d27e3710"><mml:mrow><mml:mi>V</mml:mi><mml:mo>&#8712;</mml:mo><mml:msup><mml:mi>&#8477;</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msup><mml:mi>M</mml:mi><mml:mrow><mml:mi>T</mml:mi><mml:mi>F</mml:mi></mml:mrow></mml:msup><mml:mo>+</mml:mo><mml:msup><mml:mi>N</mml:mi><mml:mrow><mml:mi>M</mml:mi><mml:mi>I</mml:mi><mml:mi>R</mml:mi></mml:mrow></mml:msup><mml:mo stretchy="false">)</mml:mo><mml:mo>&#215;</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:msup><mml:mi>M</mml:mi><mml:mrow><mml:mi>T</mml:mi><mml:mi>F</mml:mi></mml:mrow></mml:msup><mml:mo>+</mml:mo><mml:msup><mml:mi>N</mml:mi><mml:mrow><mml:mi>M</mml:mi><mml:mi>I</mml:mi><mml:mi>R</mml:mi></mml:mrow></mml:msup><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula> with <inline-formula><alternatives><inline-graphic xlink:href="kccy-15-19-1198862-eilm0011.jpg"/><mml:math id="d27e3775"><mml:mrow><mml:msup><mml:mi>U</mml:mi><mml:mi>T</mml:mi></mml:msup><mml:mi>U</mml:mi><mml:mo>=</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>
<italic>I</italic><sub><italic>M</italic></sub> and <inline-formula><alternatives><inline-graphic xlink:href="kccy-15-19-1198862-eilm0012.jpg"/><mml:math id="d27e3796"><mml:mrow><mml:msup><mml:mi>V</mml:mi><mml:mi>T</mml:mi></mml:msup><mml:mi>V</mml:mi><mml:mo>=</mml:mo><mml:msub><mml:mi>I</mml:mi><mml:mrow><mml:msup><mml:mi>M</mml:mi><mml:mrow><mml:mi>T</mml:mi><mml:mi>F</mml:mi></mml:mrow></mml:msup><mml:mo>+</mml:mo><mml:msup><mml:mi>N</mml:mi><mml:mrow><mml:mi>M</mml:mi><mml:mi>I</mml:mi><mml:mi>R</mml:mi></mml:mrow></mml:msup></mml:mrow></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>; <inline-formula><alternatives><inline-graphic xlink:href="kccy-15-19-1198862-eilm0013.jpg"/><mml:math id="d27e3835"><mml:mrow><mml:mi>&#931;</mml:mi><mml:mo>=</mml:mo><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:mtable columnalign="left"><mml:mtr><mml:mtd><mml:mrow><mml:mi mathvariant="bold">d</mml:mi><mml:mi mathvariant="bold">i</mml:mi><mml:mi mathvariant="bold">a</mml:mi><mml:mi mathvariant="bold">g</mml:mi><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mo>&#8943;</mml:mo><mml:msub><mml:mi>d</mml:mi><mml:mi>M</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow></mml:mtd><mml:mtd><mml:mrow><mml:msub><mml:mi>O</mml:mi><mml:mrow><mml:mi>M</mml:mi><mml:mo>&#215;</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:msup><mml:mi>M</mml:mi><mml:mrow><mml:mi>T</mml:mi><mml:mi>F</mml:mi></mml:mrow></mml:msup><mml:mo>+</mml:mo><mml:msup><mml:mi>N</mml:mi><mml:mrow><mml:mi>M</mml:mi><mml:mi>I</mml:mi><mml:mi>R</mml:mi></mml:mrow></mml:msup><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msub></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow><mml:mo>]</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula> with decreasing singular values <italic>d</italic><sub>1</sub> &#8805; <italic>d</italic><sub>2</sub> &#8805; &#183;&#183;&#183; &#8805; <italic>d</italic><sub><italic>m</italic></sub> &#8805; &#183;&#183;&#183; &#8805; <italic>d</italic><sub><italic>M</italic></sub> &#8805; 0; <bold>diag</bold>(<italic>d</italic><sub>1</sub>,&#183;&#183;&#183;,<italic>d</italic><sub><italic>M</italic></sub>) denotes a square diagonal matrix with the elements <italic>d</italic><sub>1</sub>, &#183;&#183;&#183;, <italic>d</italic><sub><italic>M</italic></sub>; <inline-formula><alternatives><inline-graphic xlink:href="kccy-15-19-1198862-eilm0014.jpg"/><mml:math id="d27e3967"><mml:mrow><mml:msub><mml:mi>O</mml:mi><mml:mrow><mml:mi>M</mml:mi><mml:mo>&#215;</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:msup><mml:mi>M</mml:mi><mml:mrow><mml:mi>T</mml:mi><mml:mi>F</mml:mi></mml:mrow></mml:msup><mml:mo>+</mml:mo><mml:msup><mml:mi>N</mml:mi><mml:mrow><mml:mi>M</mml:mi><mml:mi>I</mml:mi><mml:mi>R</mml:mi></mml:mrow></mml:msup><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msub></mml:mrow></mml:math></alternatives></inline-formula> representing zeros matrix with dimension <italic>M</italic> by <italic>M</italic><sup><italic>TF</italic></sup> + <italic>N</italic><sup><italic>MIR</italic></sup>; and <inline-formula><alternatives><inline-graphic xlink:href="kccy-15-19-1198862-eilm0015.jpg"/><mml:math id="d27e4020"><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mrow><mml:msup><mml:mi>M</mml:mi><mml:mrow><mml:mi>T</mml:mi><mml:mi>F</mml:mi></mml:mrow></mml:msup><mml:mo>+</mml:mo><mml:msup><mml:mi>N</mml:mi><mml:mrow><mml:mi>M</mml:mi><mml:mi>I</mml:mi><mml:mi>R</mml:mi></mml:mrow></mml:msup></mml:mrow></mml:msub></mml:mrow></mml:math></alternatives></inline-formula> indicates the <italic>M</italic><sup><italic>TF</italic></sup> + <italic>N</italic><sup><italic>MIR</italic></sup> by <italic>M</italic><sup><italic>TF</italic></sup> + <italic>N</italic><sup><italic>MIR</italic></sup> identity.</p><p>Moreover, the eigen expression fraction <inline-formula><alternatives><inline-graphic xlink:href="kccy-15-19-1198862-eilm0016.jpg"/><mml:math id="d27e4077"><mml:mstyle displaystyle="true"><mml:mrow><mml:msub><mml:mi>E</mml:mi><mml:mi>m</mml:mi></mml:msub></mml:mrow></mml:mstyle></mml:math></alternatives></inline-formula> was defined as <italic>E</italic><sub><italic>m</italic></sub> = <italic>d</italic><sub><italic>m</italic></sub><sup>2</sup>/<inline-formula><alternatives><inline-graphic xlink:href="kccy-15-19-1198862-eilm0017.jpg"/><mml:math id="d27e4103"><mml:mrow><mml:mstyle displaystyle="false"><mml:msubsup><mml:mo>&#8721;</mml:mo><mml:mrow><mml:mi>m</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>M</mml:mi></mml:msubsup><mml:mrow><mml:msubsup><mml:mi>d</mml:mi><mml:mi>m</mml:mi><mml:mn>2</mml:mn></mml:msubsup></mml:mrow></mml:mstyle></mml:mrow></mml:math></alternatives></inline-formula> (i.e., the normalization of singular values). We could then select the top <italic>L</italic> singular vectors <italic>V</italic><sub><italic>L</italic></sub> of <italic>V</italic> such that <inline-formula><alternatives><inline-graphic xlink:href="kccy-15-19-1198862-eilm0018.jpg"/><mml:math id="d27e4143"><mml:mrow><mml:mstyle displaystyle="false"><mml:msubsup><mml:mo>&#8721;</mml:mo><mml:mrow><mml:mi>m</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>L</mml:mi></mml:msubsup><mml:mrow><mml:msub><mml:mi>E</mml:mi><mml:mi>m</mml:mi></mml:msub></mml:mrow></mml:mstyle></mml:mrow></mml:math></alternatives></inline-formula> &#8805; 0.85 with the minimal <italic>L</italic>. Therefore, the <italic>L</italic> principal components contained 85% of the principal structure of the network from the energy viewpoint. Projecting the regulation matrix <italic>R</italic> to the top <italic>L</italic> principal singular vectors <italic>V</italic><sub><italic>L</italic></sub> was performed as follows:<disp-formula id="M0012"><label>(12)</label><alternatives><graphic xlink:href="kccy-15-19-1198862-em0012.jpg" position="float" orientation="portrait"/><mml:math id="d27e4189"><mml:mrow><mml:mi>S</mml:mi><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>l</mml:mi></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:msub><mml:mi>r</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:msub><mml:mi>v</mml:mi><mml:mi>l</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:mtext>&#8201;</mml:mtext><mml:mtext>&#160;for</mml:mtext><mml:mtext>&#8201;</mml:mtext><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mo>&#8230;</mml:mo><mml:mo>,</mml:mo><mml:mi>M</mml:mi><mml:mo>,</mml:mo><mml:mtext>&#8201;</mml:mtext><mml:mtext>and</mml:mtext><mml:mtext>&#8201;</mml:mtext><mml:mi>l</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mo>&#8230;</mml:mo><mml:mo>,</mml:mo><mml:mi>L</mml:mi></mml:mrow></mml:math></alternatives></disp-formula>where <italic>r</italic><sub><italic>i</italic></sub> and <italic>v</italic><sub><italic>l</italic></sub> denote the <italic>i</italic>-th row vectors of <italic>R</italic> and the <italic>l</italic>-th column vectors of the top <italic>L</italic> principal singular vectors <italic>V</italic><sub><italic>L</italic></sub>, respectively.</p><p>Finally, we calculated the dependence (or projection) of the <italic>i</italic>-th gene relative to the top <italic>L</italic> principal singular vectors <italic>V</italic><sub><italic>L</italic></sub> by the following 2-norm projection value (or PGNP projection value):<disp-formula id="M0013"><label>(13)</label><alternatives><graphic xlink:href="kccy-15-19-1198862-em0013.jpg" position="float" orientation="portrait"/><mml:math id="d27e4315"><mml:mrow><mml:mi>P</mml:mi><mml:mtext>(</mml:mtext><mml:mi>i</mml:mi><mml:mtext>)</mml:mtext><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mrow><mml:mo minsize="18pt">[</mml:mo><mml:mrow><mml:mstyle displaystyle="true"><mml:munderover><mml:mo>&#8721;</mml:mo><mml:mrow><mml:mi>l</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>L</mml:mi></mml:munderover><mml:mrow><mml:msup><mml:mrow><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:mi>S</mml:mi><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>l</mml:mi></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow><mml:mo>]</mml:mo></mml:mrow></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mstyle></mml:mrow><mml:mo minsize="18pt">]</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>/</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo>,</mml:mo><mml:mtext>&#8201;</mml:mtext><mml:mtext>&#160;for</mml:mtext><mml:mtext>&#8201;</mml:mtext><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mo>&#8230;</mml:mo><mml:mo>,</mml:mo><mml:mi>M</mml:mi></mml:mrow></mml:math></alternatives></disp-formula></p><p>If the <italic>i</italic>-th gene has a large <italic>P</italic>(<italic>i</italic>), the gene <italic>i</italic> is more related to the top <italic>L</italic> principal singular vectors <italic>V</italic><sub><italic>L</italic></sub> (i.e., more principal in the GECN).</p><p>We defined an upper threshold (&#8805; <italic>d</italic><sub><italic>th</italic></sub>) of the PGNP projection value to choose the core cell cycle genes of the core GECN. The TFs and miRNAs that regulated core cell cycle genes, were also considered as the core TFs and miRNAs of the core GECN, respectively. When we defined <italic>d</italic><sub><italic>th</italic></sub> = 0.001 and 0.1 in HeLa and ES cells, respectively, we obtained the specific GECNs and the common core GECN (<xref ref-type="fig" rid="f0004">Fig.&#160;4</xref>). According to the specific GECNs in HeLa and ES cells, we could unravel the carcinogenic mechanism in cervical cells and stemness mechanism in ES cells. The specific GECN in HeLa cells also allowed us to propose potential multiple drugs for the treatment of cervical cancer.
<fig id="f0004" orientation="portrait" position="float"><label>Figure 4.</label><caption><p>Specific and common core GECNs of HeLa cells and ESCs. Specific and common core networks were selected by PGNP with 0.001 (HeLa cells) and 0.1 (ESCs) thresholds. For each core network, inner circles contain miRNAs; middle circles correspond to cell cycle genes; and outer circles include TFs.</p></caption><graphic xlink:href="kccy-15-19-1198862-g004"/></fig>
</p></sec><sec id="s0002-0009"><title>Drug mining and design through the specific GECN of HeLa cells</title><p>To design multiple drugs with minimal side-effects for the treatment of cervical cancer based on the core GECN in HeLa cells, we considered 2 databases, the Connectivity Map (CMap)<xref rid="cit0051" ref-type="bibr"><sup>51</sup></xref> and the Drug Gene Interaction Database (DGIdb).<xref rid="cit0052" ref-type="bibr"><sup>52</sup></xref> CMap contains the genome-wide microarray data of 5 cell lines (HL60, MCF7, PC3, SKMEL5, and ssMCF7) in response to 1,327 drugs; while DGIdb comprises a drug&#8211;gene interaction database. Multiple drug therapy induces a genome-wide response. The strategy of multiple drug screening is that multiple drugs should inhibit the highly expressed cell cycle genes in the principal GECN of HeLa cells and activate the lowly expressed cell cycle genes, but have no influence on common core cell cycle genes in the core GECN. The binding protein substrates of the designed multiple drugs could also be obtained using the DGIdb. This strategy leads to improved drug safety and efficacy in the treatment of cervical cancer.</p></sec></sec><sec id="s0003"><title>Results and discussion</title><sec id="s0003-0001"><title>Results of cell cycle projection</title><p>By applying the cell cycle projection method in (<xref ref-type="disp-formula" rid="M0003">3</xref>) to genome-wide high-throughput expression data of HeLa and ES cells (see <xref ref-type="sec" rid="s0002">Material and Methods</xref>), we identified 303 cell cycle genes (46 in G1; 76 in S; 96 in G2; and 85 in M phase) in HeLa cells (<xref ref-type="fig" rid="f0002">Fig.&#160;2A</xref> and Table&#160;S1) and 299 (105 in G1; 108 in S; 73 in G2; and 13 in M phase) in ESCs (<xref ref-type="fig" rid="f0002">Fig.&#160;2B</xref> and Table&#160;S2). HeLa and ES cell cycle genes were validated by their expression Z scores (<xref ref-type="fig" rid="f0002">Fig.&#160;2A and B</xref>, respectively). The five phase-specific genes with top maximal phase-specific ability, i.e., <italic>ai,k</italic>* in (<xref ref-type="disp-formula" rid="M0003">3</xref>) in HeLa and ES cells are shown in <xref ref-type="table" rid="t0001">Table&#160;1</xref>. The identified phase-specific genes (or cell cycle genes) of HeLa and ES cells are shown in Tables&#160;S1 and S2, respectively. We only identified 13 genes in the M phase of ESCs. Of these, <italic>HSPA8</italic> has been reported as a constitutively expressed gene involved in M phase regulation.<xref rid="cit0053" ref-type="bibr"><sup>53</sup></xref> Therefore, we suggest that M phase-specific genes, which may be the constitutively expressed, could play an important role in promoting properly timed cell cycle exit.</p></sec><sec id="s0003-0002"><title>Real and core GECNs in HeLa and ES cells</title><p>We applied system identification and AIC to the dynamic model of GECN using genome-wide high-throughput data in HeLa and ES cells. We identified the real GECNs in HeLa and ES cells based on cell cycle genes resulting from cell cycle projection (<xref ref-type="fig" rid="f0003">Fig.&#160;3A and B</xref>, respectively). We have removed 94 and 24 genes, which were neither regulated by TFs nor by miRNAs in the real GECNs of HeLa (<xref ref-type="fig" rid="f0003">Fig.&#160;3A</xref>) and ES (<xref ref-type="fig" rid="f0003">Fig.&#160;3B</xref>) cells, respectively. The results showed that the numbers of G1 and S phase TFs and genes, and G2 phase TFs in HeLa cells decreased significantly compared to ES cells, while the numbers of M phase TFs and genes in HeLa increased significantly with respect to ES cells. Additionally, the numbers of G1, S, and G2 phase TF regulations in HeLa cells decreased, while the number of M phase TF regulations increased compared to ES cells. These results support the notion that the immortal nature of HeLa cells depends on dysregulation of genes controlling the G1/G2 checkpoint and cell cycle exit. Moreover, we identified 3 cell cycle genes expressed in the same phase in HeLa and ES cells: <italic>CCNE1/2</italic> in G1, <italic>CDK1</italic> in G2, and <italic>CDC20</italic> in M phase. This finding is supported by cell cycle studies of human cancer <xref rid="cit0054" ref-type="bibr"><sup>54,55</sup></xref> and human stem cells.<xref rid="cit0033" ref-type="bibr"><sup>33</sup></xref></p><p>By applying PGNP to the real GECNs (<xref ref-type="fig" rid="f0003">Fig.&#160;3</xref> and <xref ref-type="sec" rid="s0002">Material and Methods</xref>), we identified the core GECNs, including the specific GECNs of HeLa and ES cells and the core GECN common to HeLa and ES cells. These networks (<xref ref-type="fig" rid="f0004">Fig.&#160;4</xref>) represent the significant regulation networks of real GECNs (<xref ref-type="fig" rid="f0003">Fig.&#160;3</xref>). As such, they could offer a lot of useful information for carcinogenesis studies. In the common core GECN, we identified 10 common TFs and 6 common cell cycle genes: <italic>PLK1, TOP2A, AURKB, FAM83D, HJURP</italic>, and <italic>HMMR</italic>, which are involved in chromosome instability and G2/M checkpoint in HeLa and ES cells. As a result, we suggest that they are housekeeping genes for cell cycle progression. The dysregulation of the common core genes in HeLa cells could promote carcinogenesis during cellular reprogramming. The common core genes can be considered in the multiple drug design of cervical cancer to help avoid side-effects. Additionally, this result showed that the number of TFs and their regulation increased significantly in HeLa cells compared to ESCs, while at the same time the number of miRNA regulations decreased. Therefore, we suggest that the dysregulations of miRNAs play an important role in cervical carcinogenesis.</p></sec><sec id="s0003-0003"><title>Carcinogenic mechanism of the specific GECN in HeLa cells</title><p>In order to unravel the cervical carcinogenic mechanism, we identified the principal GECN. We defined the principal network as that containing the cell cycle genes with the top PGNP projection values and assumed that each of the 4 cell cycle phase groups involved at least one cell cycle gene. We then identified the principal GECN of HeLa cells (<xref ref-type="fig" rid="f0005">Fig.&#160;5A</xref>) from its specific GECN (<xref ref-type="fig" rid="f0004">Fig.&#160;4</xref>). Owing to the direct effects of DNA methylation on the binding affinities of miRNAs, RNA polymerase, and transcription factors (TFs) on target genes,<xref rid="cit0056" ref-type="bibr"><sup>56</sup></xref> we assumed that the change of basal level between HeLa and ES cells in the dynamic model (<xref ref-type="disp-formula" rid="M0004">4</xref>) would indicate the occurrence of methylation on gene <italic>i</italic>. Thus, we identified 5 common core cell cycle genes from the common core GECN as potentially methylated: <italic>PLK1, TOP2A, AURKB, HJURP</italic>, and <italic>HMMR</italic> (<xref ref-type="fig" rid="f0004">Fig.&#160;4</xref>). In recent studies, methylation of <italic>PLK1</italic>
<xref rid="cit0057" ref-type="bibr"><sup>57</sup></xref> and genetic mutations of <italic>PLK1</italic>
<xref rid="cit0058" ref-type="bibr"><sup>58</sup></xref> and <italic>TOP2A</italic>
<xref rid="cit0059" ref-type="bibr"><sup>59</sup></xref> have been reported in human cancers. Furthermore, we used the genome-wide high-throughput DNA methylation profile of human cervical cancer from TCGA and ESCs <xref rid="cit0041" ref-type="bibr"><sup>41</sup></xref> to validate our findings. We found that the identified genes presented a different DNA methylation pattern between HeLa and ES cells: <italic>PLK1</italic> (<italic>p</italic>-value &lt; 3.708 &#215; 10<sup>&#8722;211</sup>), <italic>TOP2A</italic> (<italic>p</italic>-value &lt; 7.65 &#215; 10<sup>&#8722;52</sup>), <italic>AURKB</italic> (<italic>p</italic>-value &lt; 3.18 &#215; 10<sup>&#8722;197</sup>), <italic>HJURP</italic> (<italic>p</italic>-value &lt; 2.73 &#215; 10<sup>&#8722;200</sup>), and <italic>HMMR</italic> (<italic>p</italic>-value &lt; 3.36 &#215; 10<sup>&#8722;165</sup>). These results revealed that DNA methylation played a critical role in dysregulating chromosome stability and G2/M checkpoint in HeLa cells. The dysregulation of miR-100, miR-192, miR-124, and let-7b (<italic>p</italic>-value &lt; 1.00 &#215; 10<sup>&#8722;16</sup>) in HeLa cells (<xref ref-type="fig" rid="f0004">Fig.&#160;4</xref>) could trigger DNA repair and cell apoptosis signals to counteract the accumulated mutations and methylations. However, cervical cancer cells do not undergo apoptosis,<xref rid="cit0060" ref-type="bibr"><sup>60</sup></xref> instead leading to chromosome instability and the accumulation of mutations and methylations that lead to subsequent phenotypic changes,<xref rid="cit0061" ref-type="bibr"><sup>61,62</sup></xref> which finally induce carcinogenesis. Interestingly, we report that the expression of <italic>HMMR</italic> changes from G2 phase in ESCs to M phase in HeLa cells. Normally, HMMR must be degraded in G2/M to prevent uncontrolled proliferation.<xref rid="cit0063" ref-type="bibr"><sup>63</sup></xref> However, in HeLa cells <italic>HMMR</italic> expression is enhanced in M phase, which could lead to an abnormal G2/M checkpoint. We found that miR-99A inhibited the expression of <italic>HMMR</italic> (<italic>p</italic>-value &lt; 1.00 &#215; 10<sup>&#8722;16</sup>) in G2 phase of ESCs whereas <italic>HIF1A</italic> up-regulated <italic>HMMR</italic> (<italic>p</italic>-value &lt; 1.00 &#215; 10<sup>&#8722;16</sup>) in M phase of HeLa cells. Hence, compared to ESCs, miR-99A and <italic>HIF1A</italic> dysregulation leads to phase alteration of <italic>HMMR</italic> expression in HeLa cells, which may further promote carcinogenesis of cervical cells.
<fig id="f0005" orientation="portrait" position="float"><label>Figure 5.</label><caption><p>Principal networks of HeLa (A) and ES (B) cells. To find the principal networks, we assumed that they contained cell cycle genes with top PGNP projection values and that each of the 4 cell cycle phase groups involved at least one cell cycle gene. We identified the principal GECNs from the specific GECNs shown in <xref ref-type="fig" rid="f0004">Figure&#160;4</xref>. Genes/TFs/miRNAs in blue and red denote activated expression in HeLa and ES cells, respectively (<italic>p</italic>-value &#8804; 0.05).</p></caption><graphic specific-use="web-only" xlink:href="kccy-15-19-1198862-g005"/></fig>
</p><p>To date, cervical cancer has been proposed to be a leading cause of death in women. Current treatment strategies, including chemotherapy and surgery, do not provide a permanent cure but prolong the patient's survival.<xref rid="cit0064" ref-type="bibr"><sup>64</sup></xref>. To unravel carcinogenic mechanisms underlying cervical cancer and develop a new drug strategy, we applied the big mechanism analysis to the principal GECN in HeLa cells (<xref ref-type="fig" rid="f0005">Fig.&#160;5A</xref>) using the gene ontology tool DAVID (<ext-link ext-link-type="uri" xlink:href="https://david.ncifcrf.gov/">https://david.ncifcrf.gov/</ext-link>) (<xref ref-type="fig" rid="f0006">Fig.&#160;6A</xref>).<xref rid="cit0065" ref-type="bibr"><sup>65</sup></xref> We identified 12 cell cycle genes: <italic>HIS1H2AG, ANKRD1, ARID5B, HIST1H2AJ, HIST1H4L, CDCA2, NUF2, PIF1, STAMBPL1, CKAP2L, TROAP</italic>, and <italic>ZNF165</italic>, which could be methylated due to their basal level changes between HeLa and ES cells in (4). It has been reported that <italic>NUF2, TROAP, STAMBPL1</italic>, and <italic>ARID5B</italic> can be methylated in cancers.<xref rid="cit0066" ref-type="bibr"><sup>66-69</sup></xref> Furthermore, we used the DNA methylation profile of human cervical cancer and ESCs to validate our findings. Results indicated that 8 cell cycle genes presented a significantly different methylation pattern between HeLa and ES cells, including <italic>ANKRD1</italic> (<italic>p</italic>-value &lt; 1.70 &#215; 10<sup>&#8722;9</sup>), <italic>ARID5B</italic> (<italic>p</italic>-value &lt; 5.00 &#215; 10<sup>&#8722;84</sup>), <italic>CDCA2</italic> (<italic>p</italic>-value &lt; 2.34 &#215; 10<sup>&#8722;57</sup>), <italic>PIF1</italic> (<italic>p</italic>-value &lt; 6.08 &#215; 10<sup>&#8722;39</sup>), <italic>STAMBPL1</italic> (<italic>p</italic>-value &lt; 4.31 &#215; 10<sup>&#8722;24</sup>), <italic>TROAP</italic> (<italic>p</italic>-value &lt; 7.65 &#215; 10<sup>&#8722;52</sup>), <italic>ZNF165</italic> (<italic>p</italic>-value &lt;1.08 &#215; 10<sup>&#8722;147</sup>), and <italic>HIST1H2AJ</italic> (<italic>p</italic>-value &lt; 7.98 &#215; 10<sup>&#8722;3</sup>). In addition, <italic>HIST1H4L</italic> was also characterized by a minor change in DNA methylation pattern (<italic>p</italic>-value &lt; 2.47 &#215; 10<sup>&#8722;1</sup>). Therefore, we concluded that the DNA methylation profile of cervical cancer and ES cells supported our results. To this end, <italic>ANKRD1, ARID5B, CKAP2L</italic>, and <italic>TTK</italic> have also been shown to accumulate genetic mutations in cancers.<xref rid="cit0070" ref-type="bibr"><sup>70-73</sup></xref>
<fig id="f0006" orientation="portrait" position="float"><label>Figure 6.</label><caption><p>Carcinogenic and stemness mechanisms. (A) Carcinogenic mechanism of HeLa cells and (B) stemness mechanism of ES cells. Carcinogenic and stemness mechanisms were derived by applying big mechanism analysis to the principal GECN in HeLa and ES cells, respectively (<xref ref-type="fig" rid="f0005">Fig.&#160;5 A and B</xref>), using the gene ontology tool DAVID. Genes/TFs/miRNAs in blue and red denote activated expression in HeLa and ES cells, respectively (<italic>p</italic>-value &#8804; 0.05).</p></caption><graphic specific-use="web-only" xlink:href="kccy-15-19-1198862-g006"/></fig>
</p><p>Core TFs/miRNAs identified in the principal GECN of HeLa cells (<xref ref-type="fig" rid="f0005">Fig.&#160;5A</xref>) are summarized in Table&#160;S3. By integrating the results presented in <xref ref-type="fig" rid="f0005">Fig.&#160;5A</xref> and Table&#160;S3, we obtained macroscopic results (i.e., big mechanism for carcinogenesis) (<xref ref-type="fig" rid="f0006">Fig.&#160;6A</xref> and Table&#160;S4). We classified these functions into 4 cancer-associated biological processes: anti-apoptosis, metastasis, DNA repair, and proliferation (Table&#160;S4).</p><p>Cervical cancer cells maintain directly or indirectly the transduction of proliferation signals during cell cycle progression. It is likely that miR-98, miR-17, miR-34A and, miR-29C (<italic>p</italic>-value &lt; 6.70 &#215; 10<sup>&#8722;4</sup>) do not properly transduce signals from NF&#954;B and PI3K pathways resulting in uncontrolled proliferation. Therefore, we propose that cervical cancer cells maintain or enhance their proliferation ability by activating miR-98, miR-17, miR-34A, and miR-29C.</p><p>miR-192, which is affected by the TGF-&#946; pathway, is involved in cell metastasis during the intermediate cell cycle phases, G1 and G2. Our results show that miR-192 could affect metastasis by regulating <italic>FAM111B</italic> (<italic>p</italic>-value &lt; 1.00 &#215; 10<sup>&#8722;16</sup>) and <italic>ARHGAP11A</italic> (<italic>p</italic>-value &lt; 1.00 &#215; 10<sup>&#8722;16</sup>) in G1 and G2 (<xref ref-type="fig" rid="f0005">Fig.&#160;5A</xref>). Moreover, most genetic mutations and methylations could accumulate in S and G2 phase, leading to their dysregulation, which plays an important role in driving carcinogenesis in cervical cancer. Therefore, to accumulate genetic mutations and abnormal epigenetic regulations, cervical cancer robustly enhances cell survival in the unsTable&#160;S and G2 phases by genetic mutations and methylations.<xref rid="cit0061" ref-type="bibr"><sup>61</sup></xref></p><p>Furthermore, our results revealed that cancer cells enhanced cell proliferation through cell cycle progression. In normal cells, the accumulated genetic and epigenetic alterations would trigger DNA repair, which in turn induces apoptosis.<xref rid="cit0074" ref-type="bibr"><sup>74</sup></xref> However, accumulated alterations in S and G2 in HeLa cells trigger anti-apoptosis mechanisms to avoid cell death. Accumulated genomic mutations and methylations lead to phenotypic changes characteristic of cervical cancer such as altered metastatic activity in G1 and G2 phase, which may be related to failure of G1 and G2 checkpoints.</p><p>According to the causal and temporal cell cycle interplay, cervical cancer cells can potentially increase DNA replication through regulation of miR-98 and miR-34A (<italic>p</italic>-value &lt; 6.70 &#215; 10<sup>&#8722;4</sup>), as well as methylation. Accordingly, they may further enhance the cells' metastatic ability through regulation of miR-192 in G1 phase. Subsequently, in S phase, cancer cells activate miR-34A (<italic>p</italic>-value &lt; 3.06 &#215; 10<sup>&#8722;9</sup>) and accumulate methylations and genetic mutations <xref rid="cit0062" ref-type="bibr"><sup>62</sup></xref> to alter histone regulation and modification. Taken together, these alterations can trigger cervical carcinogenesis. This is also supported by the model simulation of cancer.<xref rid="cit0061" ref-type="bibr"><sup>61</sup></xref> With alterations in histone modifications, methylated genes, such as <italic>STAMBPL1, TROAP, CDCA2, PIF1, CKAP2L</italic>, and <italic>NUF2</italic>, in G2 phase could execute numerous functions to promote carcinogenesis. At the same time, miR-192 regulates metastasis in carcinogenesis and mitosis. Furthermore, methylations, accumulated genetic mutations, and miR-192 regulation enhance the anti-apoptotic ability of HeLa cells, which in turn leads to the accumulation of additional genetic and epigenetic alterations caused by subsequent chromosome instability. Cervical cancer cells thus, cause abnormal methylations and numerous genetic mutations, which finally induce irreversible damage, i.e., cancer metastasis. At the last stage, activated miR-17 (<italic>p</italic>-value &lt; 7.76 &#215; 10<sup>&#8722;8</sup>) enhances these aberrant proliferations in M phase. Iteratively, normal cells generate the tumor and finally trigger metastasis.</p><p>Additionally, accumulated genetic mutations and DNA methylation; the dysregulation of miR-29C, miR-34A, miR-98, and miR-215 during G1, S, and G2 phases; and accumulation of miR-17 during M phase result in aberrant cell proliferation. Dysregulation of miR-192 leads to metastatic cervical cancer during G1 and G2 phases. Moreover, accumulated genetic mutations and DNA methylation during S and G2 phases, dysregulation of miR-34A during S phase, and dysregulation of miR-192 during G2 phase could trigger ineffective DNA repair and inhibit apoptosis.</p></sec><sec id="s0003-0004"><title>Stemness mechanism of specific GECNs in ESCs</title><p>To investigate the mechanism of stemness in ESCs we followed a similar strategy to that presented earlier for HeLa cells and identified the principal GECN (<xref ref-type="fig" rid="f0005">Fig.&#160;5B</xref>) from the specific GECN (<xref ref-type="fig" rid="f0004">Fig.&#160;4</xref>). We again applied the big mechanism analysis to the specific GECN of ESCs using the DAVID gene ontology tool. By assessing the basal changes between HeLa and ES cells in (4), we identified 17 genes in the principal GECN that could be methylated: <italic>RPS9, TMSB4X, DHCR24, OAZ1, EDARADD, PPIB, COX7C, RPS11, RPS14, RPS24, RPL11, RPL35, RPL36, RPLP1, ACTG1, TUBA1B</italic>, and <italic>FTL</italic> (<xref ref-type="fig" rid="f0006">Fig.&#160;6B</xref>). The methylation of <italic>EDARADD, RPS11</italic>, and <italic>RPS14</italic> has been reported earlier in cancer cells.<xref rid="cit0075" ref-type="bibr"><sup>75-77</sup></xref> We found significant changes between the DNA methylation profiles of human cervical cancer and ESCs in 14 genes: <italic>RPS9</italic> (<italic>p</italic>-value &lt; 1.91 &#215; 10<sup>&#8722;5</sup>), <italic>TMSB4X</italic> (<italic>p</italic>-value &lt; 3.77 &#215; 10<sup>&#8722;8</sup>), <italic>DHCR24</italic> (<italic>p</italic>-value &lt; 2.06 &#215; 10<sup>&#8722;44</sup>), <italic>EDARADD</italic> (<italic>p</italic>-value &lt; 4.15 &#215; 10<sup>&#8722;21</sup>), <italic>PPIB</italic> (<italic>p</italic>-value &lt; 2.86 &#215; 10<sup>&#8722;24</sup>), <italic>RPS11</italic> (<italic>p</italic>-value &lt; 1.01 &#215; 10<sup>&#8722;17</sup>), <italic>RPS14</italic> (<italic>p</italic>-value &lt; 4.47 &#215; 10<sup>&#8722;101</sup>), <italic>RPS24</italic> (<italic>p</italic>-value &lt; 4.03 &#215; 10<sup>&#8722;84</sup>), <italic>RPL11</italic> (<italic>p</italic>-value &lt; 1.37 &#215; 10<sup>&#8722;6</sup>), <italic>RPL35</italic> (<italic>p</italic>-value &lt; 9.37 &#215; 10<sup>&#8722;15</sup>), <italic>RPL36</italic> (<italic>p</italic>-value &lt; 2.45 &#215; 10<sup>&#8722;98</sup>), <italic>RPLP1</italic> (<italic>p</italic>-value &lt; 7.90 &#215; 10<sup>&#8722;8</sup>), <italic>ACTG1</italic> (<italic>p</italic>-value &lt; 9.22 &#215; 10<sup>&#8722;48</sup>), and <italic>TUBA1B</italic> (<italic>p</italic>-value &lt; 6.32 &#215; 10<sup>&#8722;13</sup>). In addition, <italic>COX7C</italic> also showed a minor change (<italic>p</italic>-value &lt; 0.289) in DNA methylation.</p><p>Using DAVID, we classified miRNAs, TFs, and cell cycle genes of the principal GECN in ESCs into 3 signaling pathways: steroid hormone-mediated, fibroblast growth factor receptor (FGFR), and apoptotic; and three biological processes: cell development, cell differentiation, and cell cycle. It has been demonstrated that mammary stem cells are highly responsive to steroid hormone signaling.<xref rid="cit0078" ref-type="bibr"><sup>78</sup></xref> One of the earliest changes in gene expression affecting the steroid hormone-mediated signaling pathway in response to a differentiation signal has been observed in mammary stem cells, supporting our findings.<xref rid="cit0079" ref-type="bibr"><sup>79</sup></xref> It has also been reported that induction of human ES cell proliferation and differentiation promotes steroidogenesis.<xref rid="cit0080" ref-type="bibr"><sup>80</sup></xref> It has been suggested that the FGFR signaling pathway is involved in the maintenance and proliferation of undifferentiated human ESCs.<xref rid="cit0073" ref-type="bibr"><sup>73</sup></xref> Furthermore, it has recently been suggested that ESC differentiation is efficiently maintained by eliminating those cells that are slow to exit pluripotency, implicating a novel role for the apoptotic signaling pathway.<xref rid="cit0081" ref-type="bibr"><sup>81</sup></xref> Therefore, we propose that the functions of the principal GECN in ESCs should play a significant role in determining the ESCs mechanisms of stemness.</p><p>miR-100, miR-124, miR-155, and miR-221 have been found in the principal GECN of ESCs. It has been reported that their regulations play an important role in modulating cell differentiation, cell migration, and cell proliferation in mammalian ESCs.<xref rid="cit0082" ref-type="bibr"><sup>82-85</sup></xref> It has also been observed that genetic and epigenetic alterations play a critical role in the development of human ESCs.<xref rid="cit0086" ref-type="bibr"><sup>86</sup></xref> However, ESCs mechanisms of stemness cannot be uncovered without the use of a systems biology approach from a genome-wide perspective. According to our analyses we proposed that the development of ESCs through the gap G1/G2 phases, is regulated by the action of E2F1, TP53, and MIR-221, involved in apoptotic signaling, and the methylation of <italic>RPS9, TMSB4X, DHCR24, OAZ1, RPLP1, ACTG1, TUBA1B</italic>, and <italic>FTL</italic>. The methylation of S phase genes <italic>EDARADD, PPIB, COX7C, RPS11, RPS14, RPS24, RPL11, RPL35</italic>, and <italic>RPL36</italic> may regulate the timing of locus replication, as previously described in mouse embryonic stem cells.<xref rid="cit0059" ref-type="bibr"><sup>59</sup></xref></p></sec><sec id="s0003-0005"><title>Multiple drug design for cervical cancer treatment by integrating cervical carcinogenic mechanisms and drug databases</title><p>By integrating the drug CMap and DGIdb databases and the cancer-specific GECN, we identified a number of drugs: methotrexate, quercetin, and mimosine. These target primarily abnormal DNA repair (i.e., ARID5B), significantly truncating numerous signal transduction proteins (i.e., CCL2). As a result, the stimulation of cancer genes in S phase is dramatically reduced; this prevents the accumulation of genetic mutations that result from chromosome instability caused by phenotypic changes (i.e., carcinogenesis) in G2 phase. At the same time, the administration of these agents should inhibit anti-apoptotic activity in S and G2 phases (i.e., CCL2 and STK17B, respectively). Consequently, abnormal cells cannot rely on apoptosis to inhibit carcinogenesis. In HeLa cells the identified drugs repress activated cell cycle genes (<italic>ARID5B, STK17B</italic>, and <italic>CCL2</italic>) (<xref ref-type="table" rid="t0002">Table&#160;2</xref>) and stimulate inhibited cell cycle TFs (PAN4, PLXNA2, HIST1H4L, and HOXA4). The drug molecules, methotrexate, quercetin and mimosine, were identified in 3 human cell lines, HL60, MCF-7, and PC3. They showed minimal side-effects on the 6 common core GECNs of ESCs: <italic>PLK1, TOP2A, AURKB, FAM83D, HJURP</italic>, and <italic>HMMR</italic> (<xref ref-type="fig" rid="f0004">Fig.&#160;4</xref>). The US Food and Drug Administration (FDA) approved Methotrexate for the treatment of acute lymphoblastic leukemia, breast cancer, gestational trophoblastic disease, head and neck cancer, lung cancer, mycosis fungoides, non-hodgkin lymphoma, and osteosarcoma. Mimosine is FDA approved for inhibiting hair growth and has been identified as a cell cycle blocker.<xref rid="cit0087" ref-type="bibr"><sup>87</sup></xref> We assumed that these genes may play essential roles in cell cycle progression. Additionally, all the drug molecules in the multiple drugs have exhibited anti-cancer effects.<xref rid="cit0088" ref-type="bibr"><sup>88-90</sup></xref>
<table-wrap id="t0002" orientation="portrait" position="float"><label>Table 2.</label><caption><p>Proposed multiple drugs for the treatment of cervical cancer.Proposed targets and structures of methotrexate, quercetin, and mimosine derived from the ZINC database. The identified drugs suppress activated cell cycle genes, such as <italic>ARID5B, STK17B</italic>, and <italic>CCL2</italic>, without affecting 6 common core genes, <italic>PLK1, TOP2A, AURKB, FAM83D, HJURP</italic>, and <italic>HMMR</italic>. The ranked list of all drugs in CMap is shown in Table&#160;S5. Methotrexate targets abnormal methylation in S phase, quercetin inhibits anti-apoptosis in G2 phase, and mimosine blocks most signal transduction and inhibits anti-apoptosis in S phase. Apoptosis reduces accumulated genetic mutations, abnormal DNA methylations, and the dysregulation of miRNAs in normal cells; thus, achieving carcinogenesis inhibition.</p></caption><!--OASIS TABLE HERE--></table-wrap>
</p></sec></sec><sec sec-type="conclusions" id="s0004"><title>Conclusions</title><p>In this study, we first applied the cell cycle projection method to genome-wide high-throughput data to identify cell cycle genes. Next, we applied a systematic method to a dynamic model of GECN to construct and then compare real GECNs of HeLa cells and ESCs. Cancer- and stem-specific GECNs were used to investigate the genetic-and-epigenetic mechanisms of cervical cancer carcinogenesis and embryonic stemness. By applying the big mechanism analysis to specific GECNs, cervical carcinogenesis and embryonic stemness could be uncovered. Furthermore, we showed that in combination with drug design, core network projection methods could be used to develop effective anticancer treatments with minimal side-effects on normal cells. Finally, we designed multiple drugs by systems pharmacology using the integrated information of cervical mechanisms and drug databases for the treatment of cervical cancer by integrating genetic-and-epigenetic regulations, omics databases, high-throughput (NGS and microarray) data, and drug databases.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SM3158"><caption><title>Supplemental Files</title></caption><media xlink:href="kccy-15-19-1198862-s001.pdf" mimetype="application" mime-subtype="pdf" orientation="portrait" id="d36e104" position="anchor"/></supplementary-material></sec></body><back><sec id="s0005" sec-type="other"><title>Disclosure of potential conflicts of interest</title><p>No potential conflicts of interest were disclosed.</p></sec><sec><title>Funding</title><p>The work was supported by the Ministry of Science and Technology of Taiwan under grant No. MOST 104-2221-E-007 -124 -MY3.</p></sec><ref-list><title>References</title><ref id="cit0001"><label>[1]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ramalho-Santos</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Yoon</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Matsuzaki</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Mulligan</surname><given-names>RC</given-names></name>, <name name-style="western"><surname>Melton</surname><given-names>DA</given-names></name></person-group>. <article-title>&#8220;Stemness&#8221;: transcriptional profiling of embryonic and adult stem cells</article-title>. <source>Science</source>
<year>2002</year>; <volume>298</volume>(<issue>5593</issue>):<fpage>597</fpage>-<lpage>600</lpage>; PMID:12228720; http://dx.doi.org/<pub-id pub-id-type="doi">10.1126/science.1072530</pub-id><?supplied-pmid 12228720?><pub-id pub-id-type="pmid">12228720</pub-id></mixed-citation></ref><ref id="cit0002"><label>[2]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Wan</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Liang</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Han</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Xie</surname><given-names>W</given-names></name></person-group>. <article-title>Knockdown of Bmi1 inhibits the stemness properties and tumorigenicity of human bladder cancer stem cell-like side population cells</article-title>. <source>Oncol Rep</source>
<year>2014</year>; <volume>31</volume>(<issue>2</issue>):<fpage>727</fpage>-<lpage>36</lpage>; PMID:24337040<?supplied-pmid 24337040?><pub-id pub-id-type="pmid">24337040</pub-id></mixed-citation></ref><ref id="cit0003"><label>[3]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Okita</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Yamanaka</surname><given-names>S</given-names></name></person-group>. <article-title>Induced pluripotent stem cells: opportunities and challenges</article-title>. <source>Philos Trans R Soc Lond B Biol Sci</source>
<year>2011</year>; <volume>366</volume>(<issue>1575</issue>):<fpage>2198</fpage>-<lpage>207</lpage>; PMID:21727125; http://dx.doi.org/<pub-id pub-id-type="doi">10.1098/rstb.2011.0016</pub-id><?supplied-pmid 21727125?><pub-id pub-id-type="pmid">21727125</pub-id></mixed-citation></ref><ref id="cit0004"><label>[4]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cai</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Weiss</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Rao</surname><given-names>MS</given-names></name></person-group>. <article-title>In search of &#8220;stemness&#8221;</article-title>. <source>Exp Hematol</source>
<year>2004</year>; <volume>32</volume>(<issue>7</issue>):<fpage>585</fpage>-<lpage>98</lpage>; PMID:15246154; http://dx.doi.org/<pub-id pub-id-type="doi">10.1016/j.exphem.2004.03.013</pub-id><?supplied-pmid 15246154?><pub-id pub-id-type="pmid">15246154</pub-id></mixed-citation></ref><ref id="cit0005"><label>[5]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bueno</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Malumbres</surname><given-names>M</given-names></name></person-group>
<article-title>MicroRNAs and the cell cycle</article-title>. <source>Biochim Biophys Acta</source>
<year>2011</year>; <volume>1812</volume>(<issue>5</issue>):<fpage>592</fpage>-<lpage>601</lpage><pub-id pub-id-type="pmid">21315819</pub-id></mixed-citation></ref><ref id="cit0006"><label>[6]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morishita</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Masaki</surname><given-names>T</given-names></name></person-group>. <article-title>miRNA in hepatocellular carcinoma</article-title>. <source>Hepatol Res</source>
<year>2015</year>; <volume>45</volume>(<issue>2</issue>):<fpage>128</fpage>-<lpage>41</lpage>; PMID:25040738; http://dx.doi.org/<pub-id pub-id-type="doi">10.1111/hepr.12386</pub-id><?supplied-pmid 25040738?><pub-id pub-id-type="pmid">25040738</pub-id></mixed-citation></ref><ref id="cit0007"><label>[7]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>CW</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>BS</given-names></name></person-group>. <article-title>Network biomarkers of bladder cancer based on a genome-wide genetic and epigenetic network derived from next-generation sequencing data</article-title>. <source>Dis Markers</source>
<year>2016</year>; <volume>2016</volume>:<fpage>4149608</fpage>, ; PMID:27034531<?supplied-pmid 27034531?><pub-id pub-id-type="pmid">27034531</pub-id></mixed-citation></ref><ref id="cit0008"><label>[8]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>CW</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>WH</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>BS</given-names></name></person-group>. <article-title>Investigating the specific core genetic-and-epigenetic networks of cellular mechanisms involved in human aging in peripheral blood mononuclear cells</article-title>.&#8221; <source>Oncotarget</source>
<year>2016</year>; <volume>7</volume>:<fpage>8556</fpage>-<lpage>79</lpage>; PMID:26895224.<?supplied-pmid 26895224?><pub-id pub-id-type="pmid">26895224</pub-id></mixed-citation></ref><ref id="cit0009"><label>[9]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thomson</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Itskovitz-Eldor</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Shapiro</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Waknitz</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Swiergiel</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Marshall</surname><given-names>VS</given-names></name>, <name name-style="western"><surname>Jones</surname><given-names>JM</given-names></name></person-group>. <article-title>Embryonic stem cell lines derived from human blastocysts</article-title>. <source>Science</source>
<year>1998</year>; <volume>282</volume>(<issue>5391</issue>):<fpage>1145</fpage>-<lpage>7</lpage>; PMID:9804556; http://dx.doi.org/<pub-id pub-id-type="doi">10.1126/science.282.5391.1145</pub-id><?supplied-pmid 9804556?><pub-id pub-id-type="pmid">9804556</pub-id></mixed-citation></ref><ref id="cit0010"><label>[10]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ivankovic</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Cukusic</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Gotic</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Skrobot</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Matijasi&#263;</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Polancec</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Rubelj</surname><given-names>I</given-names></name></person-group>. <article-title>Telomerase activity in HeLa cervical carcinoma cell line proliferation</article-title>. <source>Biogerontology</source>
<year>2007</year>; <volume>8</volume>(<issue>2</issue>):<fpage>163</fpage>-<lpage>72</lpage>; PMID:16955216; http://dx.doi.org/<pub-id pub-id-type="doi">10.1007/s10522-006-9043-9</pub-id><?supplied-pmid 16955216?><pub-id pub-id-type="pmid">16955216</pub-id></mixed-citation></ref><ref id="cit0011"><label>[11]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sa</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Das</surname><given-names>T</given-names></name></person-group>. <article-title>Anti cancer effects of curcumin: cycle of life and death</article-title>. <source>Cell Div</source>
<year>2008</year>; <volume>3</volume>:<fpage>14</fpage>; PMID:18834508; http://dx.doi.org/<pub-id pub-id-type="doi">10.1186/1747-1028-3-14</pub-id><?supplied-pmid 18834508?><pub-id pub-id-type="pmid">18834508</pub-id></mixed-citation></ref><ref id="cit0012"><label>[12]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Baskerville</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Shenoy</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Babiarz</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Baehner</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Blelloch</surname><given-names>R</given-names></name></person-group>. <article-title>Embryonic stem cell-specific microRNAs regulate the G1-S transition and promote rapid proliferation</article-title>. <source>Nat Genet</source>
<year>2008</year>; <volume>40</volume>(<issue>12</issue>):<fpage>1478</fpage>-<lpage>83</lpage>; PMID:18978791; http://dx.doi.org/<pub-id pub-id-type="doi">10.1038/ng.250</pub-id><?supplied-pmid 18978791?><pub-id pub-id-type="pmid">18978791</pub-id></mixed-citation></ref><ref id="cit0013"><label>[13]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oram</surname><given-names>SW</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>XX</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>TL</given-names></name>, <name name-style="western"><surname>Chan</surname><given-names>WY</given-names></name>, <name name-style="western"><surname>Lau</surname><given-names>YF</given-names></name></person-group>. <article-title>TSPY potentiates cell proliferation and tumorigenesis by promoting cell cycle progression in HeLa and NIH3T3 cells</article-title>. <source>BMC Cancer</source>
<year>2006</year>;<volume>6</volume>:<fpage>154</fpage>; PMID:16762081; http://dx.doi.org/<pub-id pub-id-type="doi">10.1186/1471-2407-6-154</pub-id><?supplied-pmid 16762081?><pub-id pub-id-type="pmid">16762081</pub-id></mixed-citation></ref><ref id="cit0014"><label>[14]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mine</surname><given-names>KL</given-names></name>, <name name-style="western"><surname>Shulzhenko</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Yambartsev</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Rochman</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sanson</surname><given-names>GF</given-names></name>, <name name-style="western"><surname>Lando</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Varma</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Skinner</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Volfovsky</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Deng</surname><given-names>T</given-names></name>, et&#160;al.</person-group>
<article-title>Gene network reconstruction reveals cell cycle and antiviral genes as major drivers of cervical cancer</article-title>. <source>Nat Commun</source>
<year>2013</year>;<volume>4</volume>:<fpage>1806</fpage>; PMID:23651994; http://dx.doi.org/<pub-id pub-id-type="doi">10.1038/ncomms2693</pub-id><?supplied-pmid 23651994?><pub-id pub-id-type="pmid">23651994</pub-id></mixed-citation></ref><ref id="cit0015"><label>[15]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hashem</surname><given-names>IAT</given-names></name>, <name name-style="western"><surname>Yaqoob</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Anuar</surname><given-names>NB</given-names></name> et&#160;al.</person-group>
<article-title>The rise of &#8220;big data&#8221; on cloud computing: Review and open research issues</article-title>. <source>Information Systems</source>
<year>2015</year>;<volume>47</volume>:<fpage>98</fpage>-<lpage>115</lpage>; http://dx.doi.org/<pub-id pub-id-type="doi">10.1016/j.is.2014.07.006</pub-id>.</mixed-citation></ref><ref id="cit0016"><label>[16]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cohen</surname><given-names>PR</given-names></name></person-group>. <article-title>DARPA's Big Mechanism program</article-title>. <source>Phys Biol</source>
<year>2015</year>; <volume>12</volume>(<issue>4</issue>):<fpage>045008</fpage>; PMID:26178259; http://dx.doi.org/<pub-id pub-id-type="doi">10.1088/1478-3975/12/4/045008</pub-id><?supplied-pmid 26178259?><pub-id pub-id-type="pmid">26178259</pub-id></mixed-citation></ref><ref id="cit0017"><label>[17]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>BS</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>CW</given-names></name></person-group>. <article-title>Measuring information flow in cellular networks by the systems biology method through microarray data</article-title>. <source>Front Plant Sci</source>
<year>2015</year>; <volume>6</volume>; PMID:26082788<?supplied-pmid 26082788?><pub-id pub-id-type="pmid">26082788</pub-id></mixed-citation></ref><ref id="cit0018"><label>[18]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>CW</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>BS</given-names></name></person-group>. <article-title>Identifying functional mechanisms of gene and protein regulatory networks in response to a broader range of environmental stresses</article-title>. <source>Comp Funct Genomics</source>
<year>2010</year>; Article ID 408705; PMID:20454442; http://dx.doi.org/<pub-id pub-id-type="doi">10.1155/2010/408705</pub-id><?supplied-pmid 20454442?><pub-id pub-id-type="pmid">20454442</pub-id></mixed-citation></ref><ref id="cit0019"><label>[19]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Przytycka</surname><given-names>TM</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>YA</given-names></name></person-group>. <article-title>Network integration meets network dynamics</article-title>. <source>BMC Biol</source>
<year>2010</year>; <volume>8</volume>:<fpage>48</fpage>, ; PMID:20513250; http://dx.doi.org/<pub-id pub-id-type="doi">10.1186/1741-7007-8-48</pub-id><?supplied-pmid 20513250?><pub-id pub-id-type="pmid">20513250</pub-id></mixed-citation></ref><ref id="cit0020"><label>[20]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>BS</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>CW</given-names></name></person-group>
<article-title>On the interplay between entropy and robustness of gene regulatory networks</article-title>. <source>Entropy</source>
<year>2010</year>; <volume>12</volume>(<issue>5</issue>):<fpage>1071</fpage>-<lpage>101</lpage>http://dx.doi.org/<pub-id pub-id-type="doi">10.3390/e12051071</pub-id></mixed-citation></ref><ref id="cit0021"><label>[21]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>BS</given-names></name>, <name name-style="western"><surname>Wong</surname><given-names>SW</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>CW</given-names></name></person-group>
<article-title>On the calculation of system entropy in nonlinear stochastic biological networks</article-title>. <source>Entropy</source>
<year>2015</year>; <volume>17</volume>(<issue>10</issue>):<fpage>6801</fpage>-<lpage>33</lpage>; http://dx.doi.org/<pub-id pub-id-type="doi">10.3390/e17106801</pub-id></mixed-citation></ref><ref id="cit0022"><label>[22]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schadt</surname><given-names>EE</given-names></name>, <name name-style="western"><surname>Friend</surname><given-names>SH</given-names></name>, <name name-style="western"><surname>Shaywitz</surname><given-names>DA</given-names></name></person-group>. <article-title>OPINION A network view of disease and compound screening</article-title>. <source>Nat Rev Drug Discov</source>
<year>2009</year>; <volume>8</volume>(<issue>4</issue>):<fpage>286</fpage>-<lpage>95</lpage>; PMID:19337271; http://dx.doi.org/<pub-id pub-id-type="doi">10.1038/nrd2826</pub-id><?supplied-pmid 19337271?><pub-id pub-id-type="pmid">19337271</pub-id></mixed-citation></ref><ref id="cit0023"><label>[23]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Berger</surname><given-names>SI</given-names></name>, <name name-style="western"><surname>Iyengar</surname><given-names>R</given-names></name></person-group>. <article-title>Network analyses in systems pharmacology</article-title>. <source>Bioinformatics</source>
<year>2009</year>; <volume>25</volume>(<issue>19</issue>):<fpage>2466</fpage>-<lpage>72</lpage>; PMID:19648136; http://dx.doi.org/<pub-id pub-id-type="doi">10.1093/bioinformatics/btp465</pub-id><?supplied-pmid 19648136?><pub-id pub-id-type="pmid">19648136</pub-id></mixed-citation></ref><ref id="cit0024"><label>[24]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Godoy</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Schmidt-Heck</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Natarajan</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Lucendo-Villarin</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Szkolnicka</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Asplund</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Bj&#246;rquist</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Widera</surname><given-names>A</given-names></name>, <name name-style="western"><surname>St&#246;ber</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Campos</surname><given-names>G</given-names></name>, et&#160;al.</person-group>
<article-title>Gene networks and transcription factor motifs defining the differentiation of stem cells into hepatocyte-like cells</article-title>. <source>J Hepatol</source>
<year>2015</year>; <volume>63</volume>(<issue>4</issue>):<fpage>934</fpage>-<lpage>42</lpage>; PMID:26022688; http://dx.doi.org/<pub-id pub-id-type="doi">10.1016/j.jhep.2015.05.013</pub-id><?supplied-pmid 26022688?><pub-id pub-id-type="pmid">26022688</pub-id></mixed-citation></ref><ref id="cit0025"><label>[25]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McKinney</surname><given-names>EF</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Jayne</surname><given-names>DR</given-names></name>, <name name-style="western"><surname>Lyons</surname><given-names>PA</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>KG</given-names></name></person-group>. <article-title>T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection</article-title>. <source>Nature</source>
<year>2015</year>; <volume>523</volume>(<issue>7562</issue>):<fpage>612</fpage>-<lpage>6</lpage>; PMID:26123020; http://dx.doi.org/<pub-id pub-id-type="doi">10.1038/nature14468</pub-id><?supplied-pmid 26123020?><pub-id pub-id-type="pmid">26123020</pub-id></mixed-citation></ref><ref id="cit0026"><label>[26]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Parikshak</surname><given-names>NN</given-names></name>, <name name-style="western"><surname>Gandal</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Geschwind</surname><given-names>DH</given-names></name></person-group>. <article-title>Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders</article-title>. <source>Nat Rev Genet</source>
<year>2015</year>; <volume>16</volume>(<issue>8</issue>):<fpage>441</fpage>-<lpage>58</lpage>; PMID:26149713; http://dx.doi.org/<pub-id pub-id-type="doi">10.1038/nrg3934</pub-id><?supplied-pmid 26149713?><pub-id pub-id-type="pmid">26149713</pub-id></mixed-citation></ref><ref id="cit0027"><label>[27]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Banyai</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Baidi</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Coudreuse</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Szilagyi</surname><given-names>Z</given-names></name></person-group>. <article-title>Cdk1 activity acts as a quantitative platform for coordinating cell cycle progression with periodic transcription</article-title>. <source>Nat Commun</source>
<year>2016</year>; <volume>7</volume>:<fpage>11161</fpage>; PMID:27045731; http://dx.doi.org/<pub-id pub-id-type="doi">10.1038/ncomms11161</pub-id><?supplied-pmid 27045731?><pub-id pub-id-type="pmid">27045731</pub-id></mixed-citation></ref><ref id="cit0028"><label>[28]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Young</surname><given-names>TR</given-names></name>, <name name-style="western"><surname>Fernandez</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Buckalew</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Moses</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Boczko</surname><given-names>EM</given-names></name></person-group>. <article-title>Clustering in cell cycle dynamics with general response/signaling feedback</article-title>. <source>J Theor Biol</source>
<year>2012</year>; <volume>292</volume>:<fpage>103</fpage>-<lpage>15</lpage>; PMID:22001733; http://dx.doi.org/<pub-id pub-id-type="doi">10.1016/j.jtbi.2011.10.002</pub-id><?supplied-pmid 22001733?><pub-id pub-id-type="pmid">22001733</pub-id></mixed-citation></ref><ref id="cit0029"><label>[29]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bell</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Hubbard</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Chettier</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Miller</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Kapahi</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Tarnopolsky</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sahasrabuhde</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Melov</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Hughes</surname><given-names>RE</given-names></name></person-group>. <article-title>A human protein interaction network shows conservation of aging processes between human and invertebrate species</article-title>. <source>Plos Genet</source>
<year>2009</year>; <volume>5</volume>(<issue>3</issue>): PMID:19293945<?supplied-pmid 19293945?><pub-id pub-id-type="pmid">19293945</pub-id></mixed-citation></ref><ref id="cit0030"><label>[30]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Drozdov</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Tsoka</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ouzounis</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Shah</surname><given-names>AM</given-names></name></person-group>. <article-title>Genome-wide expression patterns in physiological cardiac hypertrophy</article-title>. <source>BMC Genomics</source>
<year>2010</year>; <volume>11</volume>:<fpage>557</fpage>; PMID:20937113; http://dx.doi.org/<pub-id pub-id-type="doi">10.1186/1471-2164-11-557</pub-id><?supplied-pmid 20937113?><pub-id pub-id-type="pmid">20937113</pub-id></mixed-citation></ref><ref id="cit0031"><label>[31]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sandmann</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Girardot</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Brehme</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Tongprasit</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Stolc</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Furlong</surname><given-names>EE</given-names></name></person-group>. <article-title>A core transcriptional network for early mesoderm development in Drosophila melanogaster</article-title>. <source>Genes Dev</source>
<year>2007</year>; <volume>21</volume>(<issue>4</issue>):<fpage>436</fpage>-<lpage>49</lpage>; PMID:17322403; http://dx.doi.org/<pub-id pub-id-type="doi">10.1101/gad.1509007</pub-id><?supplied-pmid 17322403?><pub-id pub-id-type="pmid">17322403</pub-id></mixed-citation></ref><ref id="cit0032"><label>[32]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Iyengar</surname><given-names>R</given-names></name></person-group>. <article-title>Systems pharmacology: network analysis to identify multiscale mechanisms of drug action</article-title>. <source>Annu Rev Pharmacol Toxicol</source>
<year>2012</year>; <volume>52</volume>:<fpage>505</fpage>-<lpage>21</lpage>; PMID:22235860; http://dx.doi.org/<pub-id pub-id-type="doi">10.1146/annurev-pharmtox-010611-134520</pub-id><?supplied-pmid 22235860?><pub-id pub-id-type="pmid">22235860</pub-id></mixed-citation></ref><ref id="cit0033"><label>[33]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Chappell</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Trost</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Tang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Matlock</surname><given-names>BK</given-names></name>, <name name-style="western"><surname>Weller</surname><given-names>KP</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>S</given-names></name>, et&#160;al.</person-group>
<article-title>Cell-cycle control of developmentally regulated transcription factors accounts for heterogeneity in human pluripotent cells</article-title>.&#8221; <source>Stem Cell Rep</source>
<year>2013</year>; <volume>1</volume>(<issue>6</issue>):<fpage>532</fpage>-<lpage>44</lpage>; PMID:24371808; http://dx.doi.org/<pub-id pub-id-type="doi">10.1016/j.stemcr.2013.10.009</pub-id><?supplied-pmid 24371808?><pub-id pub-id-type="pmid">24371808</pub-id></mixed-citation></ref><ref id="cit0034"><label>[34]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Langmead</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Trapnell</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Pop</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Salzberg</surname><given-names>SL</given-names></name></person-group>. <article-title>Ultrafast and memory-efficient alignment of short DNA sequences to the human genome</article-title>. <source>Genome Biol</source>
<year>2009</year>; <volume>10</volume>(<issue>3</issue>):<fpage>R25</fpage>; PMID:19261174; http://dx.doi.org/<pub-id pub-id-type="doi">10.1186/gb-2009-10-3-r25</pub-id><?supplied-pmid 19261174?><pub-id pub-id-type="pmid">19261174</pub-id></mixed-citation></ref><ref id="cit0035"><label>[35]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Pertea</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Trapnell</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Pimentel</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Kelley</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Salzberg</surname><given-names>SL</given-names></name></person-group>. <article-title>TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions</article-title>. <source>Genome Biol</source>
<year>2013</year>; <volume>14</volume>(<issue>4</issue>):<fpage>R36</fpage>; PMID:23618408; http://dx.doi.org/<pub-id pub-id-type="doi">10.1186/gb-2013-14-4-r36</pub-id><?supplied-pmid 23618408?><pub-id pub-id-type="pmid">23618408</pub-id></mixed-citation></ref><ref id="cit0036"><label>[36]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Trapnell</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Williams</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>Pertea</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Mortazavi</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Kwan</surname><given-names>G</given-names></name>, <name name-style="western"><surname>van Baren</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Salzberg</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Wold</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>Pachter</surname><given-names>L</given-names></name></person-group>. <article-title>Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation</article-title>. <source>Nat Biotechnol</source>
<year>2010</year>; <volume>28</volume>(<issue>5</issue>):<fpage>511</fpage>-<lpage>5</lpage>; PMID:20436464; http://dx.doi.org/<pub-id pub-id-type="doi">10.1038/nbt.1621</pub-id><?supplied-pmid 20436464?><pub-id pub-id-type="pmid">20436464</pub-id></mixed-citation></ref><ref id="cit0037"><label>[37]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goecks</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Nekrutenko</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Taylor</surname><given-names>J</given-names></name>, <collab>Galaxy Team</collab></person-group>. <article-title>Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences</article-title>. <source>Genome Biol</source>
<year>2010</year>; <volume>11</volume>(<issue>8</issue>):<fpage>R86</fpage>; PMID:20738864; http://dx.doi.org/<pub-id pub-id-type="doi">10.1186/gb-2010-11-8-r86</pub-id><?supplied-pmid 20738864?><pub-id pub-id-type="pmid">20738864</pub-id></mixed-citation></ref><ref id="cit0038"><label>[38]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blankenberg</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Von Kuster</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Coraor</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Ananda</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Lazarus</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Mangan</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Nekrutenko</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Taylor</surname><given-names>J</given-names></name></person-group>. <article-title>Galaxy: a web-based genome analysis tool for experimentalists</article-title>. <source>Curr Protoc Mol Biol</source>
<year>2010</year>; vol. <volume>Chapter 19</volume>, pp. <fpage>Unit 19 10 1&#8211;21</fpage>; PMID:20069535; http://dx.doi.org/<pub-id pub-id-type="doi">10.1002/0471142727</pub-id><?supplied-pmid 20069535?><pub-id pub-id-type="pmid">20069535</pub-id></mixed-citation></ref><ref id="cit0039"><label>[39]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Giardine</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Riemer</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Hardison</surname><given-names>RC</given-names></name>, <name name-style="western"><surname>Burhans</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Elnitski</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Shah</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Blankenberg</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Albert</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Taylor</surname><given-names>J</given-names></name>, et&#160;al.</person-group>
<article-title>Galaxy: a platform for interactive large-scale genome analysis</article-title>. <source>Genome Res</source>
<year>2005</year>; <volume>15</volume>(<issue>10</issue>):<fpage>1451</fpage>-<lpage>5</lpage>; PMID:16169926; http://dx.doi.org/<pub-id pub-id-type="doi">10.1101/gr.4086505</pub-id><?supplied-pmid 16169926?><pub-id pub-id-type="pmid">16169926</pub-id></mixed-citation></ref><ref id="cit0040"><label>[40]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sadasivam</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Duan</surname><given-names>S</given-names></name>, <name name-style="western"><surname>DeCaprio</surname><given-names>JA</given-names></name></person-group>. <article-title>The MuvB complex sequentially recruits B-Myb and FoxM1 to promote mitotic gene expression</article-title>. <source>Genes Dev</source>
<year>2012</year>; <volume>26</volume>(<issue>5</issue>):<fpage>474</fpage>-<lpage>89</lpage>; PMID:22391450<?supplied-pmid 22391450?><pub-id pub-id-type="pmid">22391450</pub-id></mixed-citation></ref><ref id="cit0041"><label>[41]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nishino</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Toyoda</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Yamazaki-Inoue</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Fukawatase</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Chikazawa</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Sakaguchi</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Akutsu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Umezawa</surname><given-names>A</given-names></name></person-group>. <article-title>DNA Methylation Dynamics in Human Induced Pluripotent Stem Cells over Time</article-title>. <source>Plos Genet</source>
<year>2011</year>; <volume>7</volume>(<issue>5</issue>): ; PMID:21637780; http://dx.doi.org/<pub-id pub-id-type="doi">10.1371/journal.pgen.1002085</pub-id><?supplied-pmid 21637780?><pub-id pub-id-type="pmid">21637780</pub-id></mixed-citation></ref><ref id="cit0042"><label>[42]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zheng</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Tu</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Xiong</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Wei</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Xie</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Y</given-names></name></person-group>. <article-title>ITFP: an integrated platform of mammalian transcription factors</article-title>. <source>Bioinformatics</source>
<year>2008</year>; <volume>24</volume>(<issue>20</issue>):<fpage>2416</fpage>-<lpage>7</lpage>; PMID:18713790; http://dx.doi.org/<pub-id pub-id-type="doi">10.1093/bioinformatics/btn439</pub-id><?supplied-pmid 18713790?><pub-id pub-id-type="pmid">18713790</pub-id></mixed-citation></ref><ref id="cit0043"><label>[43]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bovolenta</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Acencio</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Lemke</surname><given-names>N</given-names></name></person-group>. <article-title>HTRIdb: an open-access database for experimentally verified human transcriptional regulation interactions</article-title>. <source>BMC Genomics</source>
<year>2012</year>; <volume>13</volume>:<fpage>405</fpage>; PMID:22900683; http://dx.doi.org/<pub-id pub-id-type="doi">10.1186/1471-2164-13-405</pub-id><?supplied-pmid 22900683?><pub-id pub-id-type="pmid">22900683</pub-id></mixed-citation></ref><ref id="cit0044"><label>[44]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Matys</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Kel-Margoulis</surname><given-names>OV</given-names></name>, <name name-style="western"><surname>Fricke</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Liebich</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Land</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Barre-Dirrie</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Reuter</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Chekmenev</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Krull</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hornischer</surname><given-names>K</given-names></name>, et&#160;al.</person-group>
<article-title>TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes</article-title>. <source>Nucleic Acids Res</source>
<year>2006</year>; <volume>34</volume>:<fpage>D108</fpage>-<lpage>10</lpage>; PMID:16381825; http://dx.doi.org/<pub-id pub-id-type="doi">10.1093/nar/gkj143</pub-id><?supplied-pmid 16381825?><pub-id pub-id-type="pmid">16381825</pub-id></mixed-citation></ref><ref id="cit0045"><label>[45]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Agarwal</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Bell</surname><given-names>GW</given-names></name>, <name name-style="western"><surname>Nam</surname><given-names>JW</given-names></name>, <name name-style="western"><surname>Bartel</surname><given-names>DP</given-names></name></person-group>. <article-title>Predicting effective microRNA target sites in mammalian mRNAs</article-title>. <source>eLife 2015; 4:e05005</source>; PMID:26267216; http://dx.doi.org/<pub-id pub-id-type="doi">10.7554/eLife.05005</pub-id><?supplied-pmid 26267216?><pub-id pub-id-type="pmid">26267216</pub-id></mixed-citation></ref><ref id="cit0046"><label>[46]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lu</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Vogel</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Yao</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Marcotte</surname><given-names>EM</given-names></name></person-group>. <article-title>Absolute protein expression profiling estimates the relative contributions of transcriptional and translational regulation</article-title>. <source>Nat Biotechnol</source>
<year>2007</year>; <volume>25</volume>(<issue>1</issue>):<fpage>117</fpage>-<lpage>24</lpage>; PMID:17187058; http://dx.doi.org/<pub-id pub-id-type="doi">10.1038/nbt1270</pub-id><?supplied-pmid 17187058?><pub-id pub-id-type="pmid">17187058</pub-id></mixed-citation></ref><ref id="cit0047"><label>[47]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coleman</surname><given-names>TF</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>YY</given-names></name></person-group>
<article-title>A reflective Newton method for minimizing a quadratic function subject to bounds on some of the variables</article-title>. <source>Siam J Opt</source>
<year>1996</year>; <volume>6</volume>(<issue>4</issue>):<fpage>1040</fpage>-<lpage>1058</lpage>; http://dx.doi.org/<pub-id pub-id-type="doi">10.1137/S1052623494240456</pub-id></mixed-citation></ref><ref id="cit0048"><label>[48]</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Johansson</surname><given-names>R</given-names></name></person-group>
<source><italic>System modeling and identification</italic></source>, <publisher-loc>Englewood Cliffs, NJ</publisher-loc>: <publisher-name>Prentice Hall</publisher-name>, <year>1993</year>.</mixed-citation></ref><ref id="cit0049"><label>[49]</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Pagano</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Gauvreau</surname><given-names>K</given-names></name></person-group>
<source><italic>Principles of biostatistics</italic></source>, <edition>2nd</edition> ed., <publisher-loc>Pacific Grove, CA</publisher-loc>: <publisher-name>Duxbury</publisher-name>, <year>2000</year>.</mixed-citation></ref><ref id="cit0050"><label>[50]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alter</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Brown</surname><given-names>PO</given-names></name>, <name name-style="western"><surname>Botstein</surname><given-names>D</given-names></name></person-group>. <article-title>Singular value decomposition for genome-wide expression data processing and modeling</article-title>. <source>Proc Natl Acad Sci U S A</source>
<year>2000</year>; <volume>97</volume>(<issue>18</issue>):<fpage>10101</fpage>-<lpage>6</lpage>; PMID:10963673; http://dx.doi.org/<pub-id pub-id-type="doi">10.1073/pnas.97.18.10101</pub-id><?supplied-pmid 10963673?><pub-id pub-id-type="pmid">10963673</pub-id></mixed-citation></ref><ref id="cit0051"><label>[51]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lamb</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Crawford</surname><given-names>ED</given-names></name>, <name name-style="western"><surname>Peck</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Modell</surname><given-names>JW</given-names></name>, <name name-style="western"><surname>Blat</surname><given-names>IC</given-names></name>, <name name-style="western"><surname>Wrobel</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Lerner</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Brunet</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Subramanian</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Ross</surname><given-names>KN</given-names></name>, et&#160;al.</person-group>
<article-title>The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease</article-title>. <source>Science</source>
<year>2006</year>; <volume>313</volume>(<issue>5795</issue>):<fpage>1929</fpage>-<lpage>35</lpage>; PMID:17008526; http://dx.doi.org/<pub-id pub-id-type="doi">10.1126/science.1132939</pub-id><?supplied-pmid 17008526?><pub-id pub-id-type="pmid">17008526</pub-id></mixed-citation></ref><ref id="cit0052"><label>[52]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Griffith</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Griffith</surname><given-names>OL</given-names></name>, <name name-style="western"><surname>Coffman</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Weible</surname><given-names>JV</given-names></name>, <name name-style="western"><surname>McMichael</surname><given-names>JF</given-names></name>, <name name-style="western"><surname>Spies</surname><given-names>NC</given-names></name>, <name name-style="western"><surname>Koval</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Das</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Callaway</surname><given-names>MB</given-names></name>, <name name-style="western"><surname>Eldred</surname><given-names>JM</given-names></name>, et&#160;al.</person-group>
<article-title>DGIdb: mining the druggable genome</article-title>. <source>Nat Methods</source>
<year>2013</year>; <volume>10</volume>(<issue>12</issue>):<fpage>1209</fpage>-<lpage>10</lpage>; PMID:24122041; http://dx.doi.org/<pub-id pub-id-type="doi">10.1038/nmeth.2689</pub-id><?supplied-pmid 24122041?><pub-id pub-id-type="pmid">24122041</pub-id></mixed-citation></ref><ref id="cit0053"><label>[53]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Geng</surname><given-names>YJ</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>YF</given-names></name>, <name name-style="western"><surname>Schuster</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Feng</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Lynn</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Austin</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Stoklosa</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Morrison</surname><given-names>JD</given-names></name></person-group>. <article-title>A chemical biology study of human pluripotent stem cells unveils HSPA8 as a key regulator of pluripotency</article-title>. <source>Stem Cell Rep</source>
<year>2015</year>; <volume>5</volume>(<issue>6</issue>):<fpage>1143</fpage>-<lpage>54</lpage>; PMID:26549849; http://dx.doi.org/<pub-id pub-id-type="doi">10.1016/j.stemcr.2015.09.023</pub-id><?supplied-pmid 26549849?><pub-id pub-id-type="pmid">26549849</pub-id></mixed-citation></ref><ref id="cit0054"><label>[54]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>HJ</given-names></name>, <name name-style="western"><surname>Costa</surname><given-names>RH</given-names></name>, <name name-style="western"><surname>Lau</surname><given-names>LF</given-names></name>, <name name-style="western"><surname>Tyner</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>Raychaudhuri</surname><given-names>P</given-names></name></person-group>. <article-title>Anaphase-promoting complex/cyclosome-CDH1-mediated proteolysis of the forkhead box M1 transcription factor is critical for regulated entry into S phase</article-title>. <source>Mol Cell Biol</source>
<year>2008</year>; <volume>28</volume>(<issue>17</issue>):<fpage>5162</fpage>-<lpage>71</lpage>; PMID:18573889; http://dx.doi.org/<pub-id pub-id-type="doi">10.1128/MCB.00387-08</pub-id><?supplied-pmid 18573889?><pub-id pub-id-type="pmid">18573889</pub-id></mixed-citation></ref><ref id="cit0055"><label>[55]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zafonte</surname><given-names>BT</given-names></name>, <name name-style="western"><surname>Hulit</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Amanatullah</surname><given-names>DF</given-names></name>, <name name-style="western"><surname>Albanese</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Rosen</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Reutens</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Sparano</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Lisanti</surname><given-names>MP</given-names></name>, <name name-style="western"><surname>Pestell</surname><given-names>RG</given-names></name></person-group>. <article-title>Cell-cycle dysregulation in breast cancer: breast cancer therapies targeting the cell cycle</article-title>. <source>Front Biosci</source>
<year>2000</year>; <volume>5</volume>:<fpage>D938</fpage>-<lpage>61</lpage>; PMID:11102317; http://dx.doi.org/<pub-id pub-id-type="doi">10.2741/zafonte</pub-id><?supplied-pmid 11102317?><pub-id pub-id-type="pmid">11102317</pub-id></mixed-citation></ref><ref id="cit0056"><label>[56]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weber</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hellmann</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Stadler</surname><given-names>MB</given-names></name>, <name name-style="western"><surname>Ramos</surname><given-names>L</given-names></name>, <name name-style="western"><surname>P&#228;&#228;bo</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Rebhan</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sch&#252;beler</surname><given-names>D</given-names></name></person-group>. <article-title>Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome</article-title>. <source>Nat Genet</source>
<year>2007</year>; <volume>39</volume>(<issue>4</issue>):<fpage>457</fpage>-<lpage>66</lpage>; PMID:17334365; http://dx.doi.org/<pub-id pub-id-type="doi">10.1038/ng1990</pub-id><?supplied-pmid 17334365?><pub-id pub-id-type="pmid">17334365</pub-id></mixed-citation></ref><ref id="cit0057"><label>[57]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ward</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Sivakumar</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Kanjeekal</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Hamm</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Labute</surname><given-names>BC</given-names></name>, <name name-style="western"><surname>Shum</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Hudson</surname><given-names>JW</given-names></name></person-group>. <article-title>The deregulated promoter methylation of the Polo-like kinases as a potential biomarker in hematological malignancies</article-title>. <source>Leuk Lymphoma</source>
<year>2015</year>; <volume>56</volume>(<issue>7</issue>):<fpage>2123</fpage>-<lpage>33</lpage>; PMID:25347426; http://dx.doi.org/<pub-id pub-id-type="doi">10.3109/10428194.2014.971407</pub-id><?supplied-pmid 25347426?><pub-id pub-id-type="pmid">25347426</pub-id></mixed-citation></ref><ref id="cit0058"><label>[58]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kamaraj</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Rajendran</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Sethumadhavan</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Purohit</surname><given-names>R</given-names></name></person-group>. <article-title>In-silico screening of cancer associated mutation on PLK1 protein and its structural consequences</article-title>. <source>J Mol Model</source>
<year>2013</year>; <volume>19</volume>(<issue>12</issue>):<fpage>5587</fpage>-<lpage>99</lpage>; PMID:24271645; http://dx.doi.org/<pub-id pub-id-type="doi">10.1007/s00894-013-2044-0</pub-id><?supplied-pmid 24271645?><pub-id pub-id-type="pmid">24271645</pub-id></mixed-citation></ref><ref id="cit0059"><label>[59]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hsiung</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Jannatipour</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Rose</surname><given-names>A</given-names></name>, <name name-style="western"><surname>McMahon</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Duncan</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Nitiss</surname><given-names>JL</given-names></name></person-group>. <article-title>Functional expression of human topoisomerase II alpha in yeast: mutations at amino acids 450 or 803 of topoisomerase II alpha result in enzymes that can confer resistance to anti-topoisomerase II agents</article-title>. <source>Cancer Res</source>
<year>1996</year>; <volume>56</volume>(<issue>1</issue>):<fpage>91</fpage>-<lpage>9</lpage>; PMID:8548781<?supplied-pmid 8548781?><pub-id pub-id-type="pmid">8548781</pub-id></mixed-citation></ref><ref id="cit0060"><label>[60]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Espinosa</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Cantu</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Herrera</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Lopez</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>De la Garza</surname><given-names>JG</given-names></name>, <name name-style="western"><surname>Maldonado</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Melendez-Zajgla</surname><given-names>J</given-names></name></person-group>. <article-title>Inhibitors of apoptosis proteins in human cervical cancer</article-title>. <source>BMC Cancer</source>
<year>2006</year>; <volume>6</volume>:<fpage>45</fpage>; PMID:16504151; http://dx.doi.org/<pub-id pub-id-type="doi">10.1186/1471-2407-6-45</pub-id><?supplied-pmid 16504151?><pub-id pub-id-type="pmid">16504151</pub-id></mixed-citation></ref><ref id="cit0061"><label>[61]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>BS</given-names></name>, <name name-style="western"><surname>Tsai</surname><given-names>KW</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>CW</given-names></name></person-group>. <article-title>Using nonlinear stochastic evolutionary game strategy to model an evolutionary biological network of organ carcinogenesis under a natural selection scheme</article-title>. <source>Evol Bioinform</source>
<year>2015</year>; <volume>11</volume>:<fpage>155</fpage>-<lpage>78</lpage>; PMID:26244004; http://dx.doi.org/<pub-id pub-id-type="doi">10.4137/EBO.S26195</pub-id><?supplied-pmid 26244004?><pub-id pub-id-type="pmid">26244004</pub-id></mixed-citation></ref><ref id="cit0062"><label>[62]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Woo</surname><given-names>YH</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>WH</given-names></name></person-group>. <article-title>DNA replication timing and selection shape the landscape of nucleotide variation in cancer genomes</article-title>. <source>Nat Commun</source>
<year>2012</year>; <volume>3</volume>:<fpage>1004</fpage>; PMID:22893128; http://dx.doi.org/<pub-id pub-id-type="doi">10.1038/ncomms1982</pub-id><?supplied-pmid 22893128?><pub-id pub-id-type="pmid">22893128</pub-id></mixed-citation></ref><ref id="cit0063"><label>[63]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sohr</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Engeland</surname><given-names>K</given-names></name></person-group>. <article-title>RHAMM is differentially expressed in the cell cycle and downregulated by the tumor suppressor p53</article-title>. <source>Cell Cycle</source>
<year>2008</year>; <volume>7</volume>(<issue>21</issue>):<fpage>3448</fpage>-<lpage>60</lpage>; PMID:18971636; http://dx.doi.org/<pub-id pub-id-type="doi">10.4161/cc.7.21.7014</pub-id><?supplied-pmid 18971636?><pub-id pub-id-type="pmid">18971636</pub-id></mixed-citation></ref><ref id="cit0064"><label>[64]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chhabra</surname><given-names>R</given-names></name></person-group>. <article-title>Cervical cancer stem cells: opportunities and challenges</article-title>. <source>J Cancer Res Clin Oncol</source>
<year>2015</year>; <volume>141</volume>(<issue>11</issue>):<fpage>1889</fpage>-<lpage>97</lpage>; PMID:25563493; http://dx.doi.org/<pub-id pub-id-type="doi">10.1007/s00432-014-1905-y</pub-id><?supplied-pmid 25563493?><pub-id pub-id-type="pmid">25563493</pub-id></mixed-citation></ref><ref id="cit0065"><label>[65]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>DW</given-names></name>, <name name-style="western"><surname>Sherman</surname><given-names>BT</given-names></name>, <name name-style="western"><surname>Tan</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Collins</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Alvord</surname><given-names>WG</given-names></name>, <name name-style="western"><surname>Roayaei</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Stephens</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Baseler</surname><given-names>MW</given-names></name>, <name name-style="western"><surname>Lane</surname><given-names>HC</given-names></name>, <name name-style="western"><surname>Lempicki</surname><given-names>RA</given-names></name></person-group>. <article-title>The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists</article-title>. <source>Genome Biol</source>
<year>2007</year>; <volume>8</volume>(<issue>9</issue>):<fpage>R183</fpage>; PMID:17784955; http://dx.doi.org/<pub-id pub-id-type="doi">10.1186/gb-2007-8-9-r183</pub-id><?supplied-pmid 17784955?><pub-id pub-id-type="pmid">17784955</pub-id></mixed-citation></ref><ref id="cit0066"><label>[66]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wehbe</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Henson</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Meng</surname><given-names>FY</given-names></name>, <name name-style="western"><surname>Mize-Berge</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Patel</surname><given-names>T</given-names></name></person-group>. <article-title>Interleukin-6 contributes to growth in cholangiocarcinoma cells by aberrant promoter methylation and gene expression</article-title>. <source>Cancer Res</source>
<year>2006</year>; <volume>66</volume>(<issue>21</issue>):<fpage>10517</fpage>-<lpage>24</lpage>; PMID:17079474; http://dx.doi.org/<pub-id pub-id-type="doi">10.1158/0008-5472.CAN-06-2130</pub-id><?supplied-pmid 17079474?><pub-id pub-id-type="pmid">17079474</pub-id></mixed-citation></ref><ref id="cit0067"><label>[67]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baba</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Ohtake</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Okuno</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Yokota</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Okada</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Imai</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Ni</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Meyer</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Igarashi</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Kanno</surname><given-names>J</given-names></name>, et&#160;al.</person-group>
<article-title>PKA-dependent regulation of the histone lysine demethylase complex PHF2-ARID5B</article-title>. <source>Nat Cell Biol</source>
<year>2011</year>; <volume>13</volume>(<issue>6</issue>):<fpage>668</fpage>-<lpage>75</lpage>; PMID:21532585; http://dx.doi.org/<pub-id pub-id-type="doi">10.1038/ncb2228</pub-id><?supplied-pmid 21532585?><pub-id pub-id-type="pmid">21532585</pub-id></mixed-citation></ref><ref id="cit0068"><label>[68]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sethi</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Pathak</surname><given-names>HB</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Einarson</surname><given-names>MB</given-names></name>, <name name-style="western"><surname>Vathipadiekal</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Gunewardena</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Birrer</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Godwin</surname><given-names>AK</given-names></name></person-group>. <article-title>An RNA interference lethality screen of the human druggable genome to identify molecular vulnerabilities in epithelial ovarian cancer</article-title>. <source>Plos One</source>
<year>2012</year>; <volume>7</volume>(<issue>10</issue>):<fpage>e47086</fpage>; PMID:23056589; http://dx.doi.org/<pub-id pub-id-type="doi">10.1371/journal.pone.0047086</pub-id><?supplied-pmid 23056589?><pub-id pub-id-type="pmid">23056589</pub-id></mixed-citation></ref><ref id="cit0069"><label>[69]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cheng</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Yan</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Liang</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Xia</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Feng</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Luo</surname><given-names>H</given-names></name></person-group>. <article-title>Analysis of DNA methylation patterns associated with the gastric cancer genome</article-title>. <source>Oncol Lett</source>
<year>2014</year>; <volume>7</volume>(<issue>4</issue>):<fpage>1021</fpage>-<lpage>6</lpage>; PMID:24944662<?supplied-pmid 24944662?><pub-id pub-id-type="pmid">24944662</pub-id></mixed-citation></ref><ref id="cit0070"><label>[70]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cinquetti</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Badi</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Campione</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Bortoletto</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Chiesa</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Parolini</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Camesasca</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Russo</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Taramelli</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Acquati</surname><given-names>F</given-names></name></person-group>. <article-title>Transcriptional deregulation and a missense mutation define ANKRD1 as a candidate gene for total anomalous pulmonary venous return</article-title>. <source>Hum Mutat</source>
<year>2008</year>; <volume>29</volume>(<issue>4</issue>):<fpage>468</fpage>-<lpage>74</lpage>; PMID:18273862; http://dx.doi.org/<pub-id pub-id-type="doi">10.1002/humu.20711</pub-id><?supplied-pmid 18273862?><pub-id pub-id-type="pmid">18273862</pub-id></mixed-citation></ref><ref id="cit0071"><label>[71]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Niittymaki</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Gylfe</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Laine</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Laakso</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Lehtonen</surname><given-names>HJ</given-names></name>, <name name-style="western"><surname>Kondelin</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Tolvanen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Nousiainen</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Pouwels</surname><given-names>J</given-names></name>, <name name-style="western"><surname>J&#228;rvinen</surname><given-names>H</given-names></name>, et&#160;al.</person-group>
<article-title>High frequency of TTK mutations in microsatellite-unstable colorectal cancer and evaluation of their effect on spindle assembly checkpoint</article-title>. <source>Carcinogenesis</source>
<year>2011</year>; <volume>32</volume>(<issue>3</issue>):<fpage>305</fpage>-<lpage>11</lpage>; PMID:21163887<?supplied-pmid 21163887?><pub-id pub-id-type="pmid">21163887</pub-id></mixed-citation></ref><ref id="cit0072"><label>[72]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wangpermtam</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Sanguansin</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Petmitr</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Punyarit</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Weerapradist</surname><given-names>W</given-names></name></person-group>. <article-title>Genetic alteration in oral squamous cell carcinoma detected by arbitrarily primed polymerase chain reaction</article-title>. <source>Asian Pac J Cancer Prev</source>
<year>2011</year>; <volume>12</volume>(<issue>8</issue>):<fpage>2081</fpage>-<lpage>5</lpage>; PMID:22292655<?supplied-pmid 22292655?><pub-id pub-id-type="pmid">22292655</pub-id></mixed-citation></ref><ref id="cit0073"><label>[73]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cancer Genome Atlas Research</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Kandoth</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Schultz</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Cherniack</surname><given-names>AD</given-names></name>, <name name-style="western"><surname>Akbani</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Shen</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Robertson</surname><given-names>AG</given-names></name>, <name name-style="western"><surname>Pashtan</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Shen</surname><given-names>R</given-names></name>, et&#160;al.</person-group>
<article-title>Integrated genomic characterization of endometrial carcinoma</article-title>. <source>Nature</source>
<year>2013</year>; <volume>497</volume>(<issue>7447</issue>):<fpage>67</fpage>-<lpage>73</lpage>; PMID:23636398; http://dx.doi.org/<pub-id pub-id-type="doi">10.1038/nature12113</pub-id><?supplied-pmid 23636398?><pub-id pub-id-type="pmid">23636398</pub-id></mixed-citation></ref><ref id="cit0074"><label>[74]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaina</surname><given-names>B</given-names></name></person-group>. <article-title>DNA damage-triggered apoptosis: critical role of DNA repair, double-strand breaks, cell proliferation and signaling</article-title>. <source>Biochem Pharmacol</source>
<year>2003</year>; <volume>66</volume>(<issue>8</issue>):<fpage>1547</fpage>-<lpage>54</lpage>; PMID:14555233; http://dx.doi.org/<pub-id pub-id-type="doi">10.1016/S0006-2952(03)00510-0</pub-id><?supplied-pmid 14555233?><pub-id pub-id-type="pmid">14555233</pub-id></mixed-citation></ref><ref id="cit0075"><label>[75]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Borze</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Juvonen</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Ninomiya</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Jee</surname><given-names>KJ</given-names></name>, <name name-style="western"><surname>Elonen</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Knuutila</surname><given-names>S</given-names></name></person-group>. <article-title>High-resolution oligonucleotide array comparative genomic hybridization study and methylation status of the RPS14 gene in de novo myelodysplastic syndromes</article-title>. <source>Cancer Genet Cytogenet</source>
<year>2010</year>; <volume>197</volume>(<issue>2</issue>):<fpage>166</fpage>-<lpage>73</lpage>; PMID:20193850<?supplied-pmid 20193850?><pub-id pub-id-type="pmid">20193850</pub-id></mixed-citation></ref><ref id="cit0076"><label>[76]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vizoso</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Puig</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Carmona</surname><given-names>FJ</given-names></name>, <name name-style="western"><surname>Maqueda</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Vel&#225;squez</surname><given-names>A</given-names></name>, <name name-style="western"><surname>G&#243;mez</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Labernadie</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Lugo</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Gabasa</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Rigat-Brugarolas</surname><given-names>LG</given-names></name>, et&#160;al.</person-group>
<article-title>Aberrant DNA methylation in non-small cell lung cancer-associated fibroblasts</article-title>. <source>Carcinogenesis</source>
<year>2015</year>; <volume>36</volume>(<issue>12</issue>):<fpage>1453</fpage>-<lpage>63</lpage>; PMID:26449251<?supplied-pmid 26449251?><pub-id pub-id-type="pmid">26449251</pub-id></mixed-citation></ref><ref id="cit0077"><label>[77]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yong</surname><given-names>WH</given-names></name>, <name name-style="western"><surname>Shabihkhani</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Telesca</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Tso</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Menjivar</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Wei</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Lucey</surname><given-names>GM</given-names></name>, <name name-style="western"><surname>Mareninov</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>Z</given-names></name>, et&#160;al.</person-group>
<article-title>Ribosomal proteins RPS11 and RPS20, two stress-response markers of glioblastoma stem cells, are novel predictors of poor prognosis in glioblastoma patients</article-title>. <source>PLoS One</source>
<year>2015</year>; <volume>10</volume>(<issue>10</issue>):<fpage>e0141334</fpage>; PMID:26506620; http://dx.doi.org/<pub-id pub-id-type="doi">10.1371/journal.pone.0141334</pub-id><?supplied-pmid 26506620?><pub-id pub-id-type="pmid">26506620</pub-id></mixed-citation></ref><ref id="cit0078"><label>[78]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Asselin-Labat</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Vaillant</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Sheridan</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Pal</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Simpson</surname><given-names>ER</given-names></name>, <name name-style="western"><surname>Yasuda</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Smyth</surname><given-names>GK</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>TJ</given-names></name>, <name name-style="western"><surname>Lindeman</surname><given-names>GJ</given-names></name>, et&#160;al.</person-group>
<article-title>Control of mammary stem cell function by steroid hormone signalling</article-title>. <source>Nature</source>
<year>2010</year>; <volume>465</volume>(<issue>7299</issue>):<fpage>798</fpage>-<lpage>802</lpage>; PMID:20383121; http://dx.doi.org/<pub-id pub-id-type="doi">10.1038/nature09027</pub-id><?supplied-pmid 20383121?><pub-id pub-id-type="pmid">20383121</pub-id></mixed-citation></ref><ref id="cit0079"><label>[79]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sauter</surname><given-names>CN</given-names></name>, <name name-style="western"><surname>McDermid</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Weinberg</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>Greco</surname><given-names>TL</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Murdoch</surname><given-names>FE</given-names></name>, <name name-style="western"><surname>Fritsch</surname><given-names>MK</given-names></name></person-group>. <article-title>Differentiation of murine embryonic stem cells induces progesterone receptor gene expression</article-title>. <source>Exp Cell Res</source>
<year>2005</year>; <volume>311</volume>(<issue>2</issue>):<fpage>251</fpage>-<lpage>64</lpage>; PMID:16223481; http://dx.doi.org/<pub-id pub-id-type="doi">10.1016/j.yexcr.2005.09.005</pub-id><?supplied-pmid 16223481?><pub-id pub-id-type="pmid">16223481</pub-id></mixed-citation></ref><ref id="cit0080"><label>[80]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gallego</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Porayette</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Kaltcheva</surname><given-names>MM</given-names></name>, <name name-style="western"><surname>Bowen</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Vadakkadath Meethal</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Atwood</surname><given-names>CS</given-names></name></person-group>. <article-title>The pregnancy hormones human chorionic gonadotropin and progesterone induce human embryonic stem cell proliferation and differentiation into neuroectodermal rosettes</article-title>. <source>Stem Cell Res Ther</source>
<year>2010</year>; <volume>1</volume>:<fpage>28</fpage>; PMID:20836886; http://dx.doi.org/<pub-id pub-id-type="doi">10.1186/scrt28</pub-id><?supplied-pmid 20836886?><pub-id pub-id-type="pmid">20836886</pub-id></mixed-citation></ref><ref id="cit0081"><label>[81]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>ES</given-names></name>, <name name-style="western"><surname>Reyes</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Melton</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Huskey</surname><given-names>NE</given-names></name>, <name name-style="western"><surname>Momcilovic</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Goga</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Blelloch</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Oakes</surname><given-names>SA</given-names></name></person-group>. <article-title>Fas-activated mitochondrial apoptosis culls stalled embryonic stem cells to promote differentiation</article-title>. <source>Curr Biol</source>
<year>2015</year>; <volume>25</volume>(<issue>23</issue>):<fpage>3110</fpage>-<lpage>8</lpage>; PMID:26585277; http://dx.doi.org/<pub-id pub-id-type="doi">10.1016/j.cub.2015.10.020</pub-id><?supplied-pmid 26585277?><pub-id pub-id-type="pmid">26585277</pub-id></mixed-citation></ref><ref id="cit0082"><label>[82]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Song</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Feng</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>L</given-names></name>, et&#160;al.</person-group>
<article-title>PAX6 downregulates miR-124 expression to promote cell migration during embryonic stem cell differentiation</article-title>. <source>Stem Cells Dev</source>
<year>2014</year>; <volume>23</volume>(<issue>19</issue>):<fpage>2297</fpage>-<lpage>310</lpage>; PMID:24773074; http://dx.doi.org/<pub-id pub-id-type="doi">10.1089/scd.2013.0410</pub-id><?supplied-pmid 24773074?><pub-id pub-id-type="pmid">24773074</pub-id></mixed-citation></ref><ref id="cit0083"><label>[83]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Bei</surname><given-names>YH</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Lv</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>T</given-names></name>, <name name-style="western"><surname>He</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Xiao</surname><given-names>J</given-names></name></person-group>. <article-title>MicroRNA-221 is required for proliferation of mouse embryonic stem cells via P57 targeting</article-title>. <source>Stem Cell Rev Rep</source>
<year>2015</year>; <volume>11</volume>(<issue>1</issue>):<fpage>39</fpage>-<lpage>49</lpage>; PMID:25086570; http://dx.doi.org/<pub-id pub-id-type="doi">10.1007/s12015-014-9543-y</pub-id><?supplied-pmid 25086570?><pub-id pub-id-type="pmid">25086570</pub-id></mixed-citation></ref><ref id="cit0084"><label>[84]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sato</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>XD</given-names></name>, <name name-style="western"><surname>Basma</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Togo</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Sugiura</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Nelson</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Nakanishi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kanaji</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>M</given-names></name>, et&#160;al.</person-group>
<article-title>IL-4 induces differentiation of human embryonic stem cells into fibrogenic fibroblast-like cells</article-title>. <source>J Allergy Clin Immunol</source>
<year>2011</year>; <volume>127</volume>(<issue>6</issue>):<fpage>1595</fpage>-<lpage>603</lpage>; PMID:21388667; http://dx.doi.org/<pub-id pub-id-type="doi">10.1016/j.jaci.2011.01.049</pub-id><?supplied-pmid 21388667?><pub-id pub-id-type="pmid">21388667</pub-id></mixed-citation></ref><ref id="cit0085"><label>[85]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tarantino</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Paolella</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Cozzuto</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Minopoli</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Pastore</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Parisi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Russo</surname><given-names>T</given-names></name></person-group>. <article-title>miRNA 34a, 100, and 137 modulate differentiation of mouse embryonic stem cells</article-title>. <source>FASEB J</source>
<year>2010</year>; <volume>24</volume>(<issue>9</issue>):<fpage>3255</fpage>-<lpage>63</lpage>; PMID:20439489; http://dx.doi.org/<pub-id pub-id-type="doi">10.1096/fj.09-152207</pub-id><?supplied-pmid 20439489?><pub-id pub-id-type="pmid">20439489</pub-id></mixed-citation></ref><ref id="cit0086"><label>[86]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maitra</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Arking</surname><given-names>DE</given-names></name>, <name name-style="western"><surname>Shivapurkar</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Ikeda</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Stastny</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Kassauei</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Sui</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Cutler</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Brimble</surname><given-names>SN</given-names></name>, et&#160;al.</person-group>
<article-title>Genomic alterations in cultured human embryonic stem cells</article-title>. <source>Nat Genet</source>
<year>2005</year>; <volume>37</volume>(<issue>10</issue>):<fpage>1099</fpage>-<lpage>103</lpage>; PMID:16142235; http://dx.doi.org/<pub-id pub-id-type="doi">10.1038/ng1631</pub-id><?supplied-pmid 16142235?><pub-id pub-id-type="pmid">16142235</pub-id></mixed-citation></ref><ref id="cit0087"><label>[87]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Farinelli</surname><given-names>SE</given-names></name>, <name name-style="western"><surname>Greene</surname><given-names>LA</given-names></name></person-group>. <article-title>Cell cycle blockers mimosine, ciclopirox, and deferoxamine prevent the death of PC12 cells and postmitotic sympathetic neurons after removal of trophic support</article-title>. <source>J Neurosci</source>
<year>1996</year>; <volume>16</volume>(<issue>3</issue>):<fpage>1150</fpage>-<lpage>62</lpage>; PMID:8558244<?supplied-pmid 8558244?><pub-id pub-id-type="pmid">8558244</pub-id></mixed-citation></ref><ref id="cit0088"><label>[88]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Krude</surname><given-names>T</given-names></name></person-group>. <article-title>Mimosine arrests proliferating human cells before onset of DNA replication in a dose-dependent manner</article-title>. <source>Exp Cell Res</source>
<year>1999</year>; <volume>247</volume>(<issue>1</issue>):<fpage>148</fpage>-<lpage>59</lpage>; PMID:10047457; http://dx.doi.org/<pub-id pub-id-type="doi">10.1006/excr.1998.4342</pub-id><?supplied-pmid 10047457?><pub-id pub-id-type="pmid">10047457</pub-id></mixed-citation></ref><ref id="cit0089"><label>[89]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vidya Priyadarsini</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Senthil Murugan</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Maitreyi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ramalingam</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Karunagaran</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Nagini</surname><given-names>S</given-names></name></person-group>. <article-title>The flavonoid quercetin induces cell cycle arrest and mitochondria-mediated apoptosis in human cervical cancer (HeLa) cells through p53 induction and NF-kappaB inhibition</article-title>. <source>Eur J Pharmacol</source>
<year>2010</year>; <volume>649</volume>(<issue>1&#8211;3</issue>):<fpage>84</fpage>-<lpage>91</lpage>; PMID:20858478; http://dx.doi.org/<pub-id pub-id-type="doi">10.1016/j.ejphar.2010.09.020</pub-id><?supplied-pmid 20858478?><pub-id pub-id-type="pmid">20858478</pub-id></mixed-citation></ref><ref id="cit0090"><label>[90]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Gu</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Shao</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>ZP</given-names></name></person-group>. <article-title>Nanotechnology in the management of cervical cancer</article-title>. <source>Rev Med Virol</source>
<year>2015</year>; <volume>25</volume>(<issue>Suppl 1</issue>):<fpage>72</fpage>-<lpage>83</lpage>; PMID:25752817<?supplied-pmid 25752817?><pub-id pub-id-type="pmid">25752817</pub-id></mixed-citation></ref></ref-list></back></article>